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ABSTRACT 
Diagnosis codes in administrative health databases (AHDs) are commonly used to ascertain 
chronic disease cases for research and surveillance. Low sensitivity of diagnosis codes has been 
demonstrated in many studies that validate AHDs against a gold standard data source in which 
the true disease status is known. This will result in misclassification of disease status, which can 
lead to biased prevalence estimates and loss of power to detect associations between diseases 
status and health outcomes. Model-based case detection algorithms in combination with multiple 
imputation (MI) methods in validation dataset/main dataset designs could be used to correct for 
misclassification of chronic disease status in AHDs. Under this approach, a predictive model of 
disease status (e.g., logistic model) is constructed in the validation dataset, the model parameters 
are estimated and MI methods are used to impute true disease status in the main dataset. This 
research considered scenarios that the misclassification of the observed disease status is 
independent of disease predictors and dependent on disease predictors. When the 
misclassification of the observed disease status is independent of disease predictors, the MI 
methods based on Frequentist logistic model (with and without bias correction) and Bayesian 
logistic model were compared. And when the misclassification of the observed disease status is 
dependent on disease predictors, the MI based on Frequentist logistic model with different 
variables as covariates were compared. Monte Carlo techniques were used to investigate the 
effects of the following data and model characteristics on bias and error in chronic disease 
prevalence estimates from AHDs: sensitivity of observed disease status based on diagnosis 
codes, size of the validation dataset, number of imputations, and the magnitude of measurement 
error in covariates of the predictive model. Relative bias, root mean squared error and coverage 
of 95% confidence interval were used to measure the performance. Without bias correction, the 
Bayesian MI model has lower RMSE than the Frequentist MI model. And the Frequentist MI 
model with bias correction is demonstrated via a simulation study to have superior performance 
to Bayesian MI model and the Frequentist MI model without bias correction. The results indicate 
that MI works well for measurement error correction if the missing true values are not missing 
not at random no matter whether the observed disease diagnosis is dependent on other disease 
predictors or not. Increasing the size of the validation dataset can improve the performance of MI 
better than increasing the number of imputations.
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CHAPTER 1. INTRODUCTION 
 1.1 Background 
Population-based administrative health databases (AHDs), including hospital records and 
physician claims, are widely used for chronic disease research and surveillance
1-4
. In AHDs, 
diagnostic information is usually based on the International Classification of Diseases (ICD) 
codes, which was developed by the World Health Organization. The presence or absence of a 
diagnosis code in AHD is used to ascertain disease status (i.e., disease presence/absence). 
Ascertained disease status is used to estimate prevalence and incidence in surveillance studies. 
As well, the association between disease presence and health outcomes, such as hospitalization 
or death, might also be investigated using AHDs. Accurate disease case ascertainment is 
important not only for obtaining accurate prevalence estimates but also for producing unbiased 
epidemiologic and clinical studies about disease outcomes.  
AHD was originally developed for health system management and physician remuneration. 
The accuracy of diagnoses in AHDs for research has been questioned. Validation studies, in 
which AHDs are linked, via a unique personal identifier, to a ‘gold standard’ data source in 
which the true disease status is known, have been used to assess the accuracy of diagnoses 
recorded in AHDs.  In general, these studies have demonstrated high specificity but low 
sensitivity of diagnoses
5-7
, although sensitivity and specificity will vary across chronic diseases
8
. 
Sensitivity is defined as the probability of correctly identifying disease individuals from all the 
individuals who truly have the disease, while specificity is defined as the probability of correctly 
identifying non-disease individuals from amongst those who truly do not have the disease
9
.  
Inaccuracies in diagnosis codes in AHDs lead to misclassification of observed disease 
status. In particular, low sensitivity and perfect specificity will result in under-reporting of 
disease prevalence
10,11
.  Misclassification of observed disease status can also attenuate the 
association between disease presence as a response variable and risk factors, or the association 
between disease presence as an explanatory variable and health outcomes
12
. Model-based case-
detection algorithms, which can improve sensitivity of the observed disease status without loss of 
specificity, have been proposed for AHDs as well as for other related problems
11,13
. Model-based 
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algorithms develop a predictive model for chronic disease status in a validation dataset, that is a 
dataset in which the true disease status is known and the observed disease status (i.e., ascertained 
based on diagnosis codes) is also captured. The model is then applied to another dataset, known 
as the main dataset, which only contains observed disease status, to predict true disease status. 
The model that is fitted to the validation dataset predicts true disease status from disease 
predictor variables; these predictor variables are also found in the main dataset. Examples of 
disease predictor variables could include the presence of prescription drug treatments, comorbid 
conditions, severity of illness, and demographic variables. True disease status can be predicted 
using a parametric model, such as logistic regression, or a non-parametric model, such as 
classification and regression tree (CART) analyses. Model-based case-detection algorithms have 
been shown to have better discriminative performance and lower prediction error than case-
detection algorithms based on diagnosis codes alone. However, there are several issues that arise 
in the development of the predictive model. First, some disease predictors, particularly those 
based on ICD codes, may also contain measurement/misclassification error
14
. Second, there are 
several approaches that can be used to construct model-based case-detection algorithms and it is 
not clear which approach should be preferred.   
A number of studies have proposed treating measurement error as a missing-data problem
15-
17
. In particular, multiple imputation (MI) methods have been proposed to accurately estimate 
true disease status and its variation in main/validation dataset designs. MI is a flexible technique 
that has been applied to problems of missing data
18,19
 and confidential data
20
, as well as 
measurement error
15,21,22
. A primary advantage of using a MI method is that it is relatively 
straightforward to implement, which is beneficial for applied researchers. MI methods based on 
both Frequentist and Bayesian paradigms have been proposed and applied
17,23,24
, but few, if any 
studies have compared these methods. As well, there has been limited investigation about the 
characteristics of the study design and MI methodology that may influence the performance of 
model-based case-detection algorithms. Such studies could help researchers take maximum 
advantage of AHDs for chronic disease research and surveillance.  
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1.2 Purpose and Objectives 
The purpose of this research is to investigate the performance of MI model-based case 
detection methods for estimating chronic disease prevalence in validation/main datasets designs. 
The objectives are: 
1. To investigate MI methods using Frequentist and Bayesian logistic regression model as 
predictive model; 
2. To examine characteristics of model-based case-detection algorithms that may influence 
the performance of MI methods, including sensitivity of AHD diagnosis codes, and type 
and magnitude of measurement error in the predictors of disease status; and  
3. To investigate the effects of size of the validation dataset and number of imputations on 
the performance of MI methods. 
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CHAPTER 2. LITERATURE REVIEW 
The literature review covers the following topics: measurement error, validity of diagnosis 
codes in AHD, measurement error correction methods, MI methods, and software to implement 
MI methods. 
2.1 Types of Measurement Error 
Measurement error is defined as the difference between the observed value of a variable and 
the true value of a variable. Measurement error in categorical variables is usually referred to as 
misclassification. When a categorical variable is subject to misclassification, sensitivity and 
specificity are used to quantify the accuracy of the measurement.  
Measurement error can be defined using both Classical and Berkson models
16
. For the 
Classical measurement error model, the measurement measures the truth with additive error, 
usually with homoscedastic variance. For example, in feeding studies, researchers have posited 
that protein biomarkers will capture true protein intake with added constant variability
25,26
. The 
Classical model is defined as     , where  denotes the observed variable,   denotes the 
true variable and   is the error term.  In the Berkson measurement error model, the true value 
contains more variability than the measured value. For example, in the Hanford Thyroid Disease 
Study, it is thought that the true thyroid dose equals to the measured dose plus error
27
. The 
Berkson model is      , indicating that the variability of the true variable ( ) equals the 
sum of the variability of the observed variable ( ) and error ( ). If a variable is measured 
uniquely for all individuals, measurement error is likely to follow the Classical model. For 
example, if people fill out a self-report questionnaire about their health conditions or if they get a 
blood pressure measurement, then the errors will likely follow the Classical model. However, if 
all individuals in a stratum are given the same value of the measure but the true value is specific 
to an individual, then the Berkson model is a reasonable choice.  For a given measurement error 
variance, measurement error in the Classical model results in greater loss of power than 
measurement error in the Berkson model
16
.   
Measurement error can also be characterized as differential or non-differential. Non-
differential measurement error means that the observed covariate contains no information about 
the response given the true covariate. Measurement error is non-differential if the observed 
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covariate is independent of the response, conditional on the values of the true covariate. 
Otherwise, the measurement error is differential. For example, in the Framingham study, which 
is a large cohort study about the cardiovascular disease predictors, one response of interest is the 
presence of coronary heart disease; the main predictor of interest is systolic blood pressure which 
is not possible to measure directly
28,29
. Only blood pressure measurements observed during a 
clinic visit are available. Since given the long term systolic blood pressure one visit’s measured 
blood pressure provides no information to the coronary heart disease, the measurement error is 
non-differential
30
. In AHDs when the interested response is the disease status, if the probabilities 
of mismeasurement of disease predictors are assumed to be the same for persons with the disease 
as for persons without the disease, the measurement error is non-differential. However, 
measurement error is differential if the probabilities differ for persons with and without disease. 
In case-control studies, the response is observed first and then subsequent follow-up ascertains 
the predictors of the response, which is known as recall bias, so the measurement of the 
predictors usually depend on the response and are known as differential measurement. And 
differential measurement error typically occurs in retrospective studies. If the response is 
measured after the covariates are measured, which is typical of cohort studies, measurement 
error in the covariates tends to be non-differential. Carroll et al.
16 
concluded that additive, 
unbiased, homoscedastic response measurement error in linear or nonlinear regression will result 
in increased variability of the fitted models and decreased power to detect effects of covariates. 
Misclassification of the response not only masks the features of the data but also results in bias in 
the parameter estimates.  
2.2 Measurement Error in AHD 
A number of studies have investigated the validity of diagnosis codes in AHD for 
ascertaining cases of chronic disease.
31-35
 Under reporting of disease cases, in which the 
observed value has high specificity (i.e., close to 1.00) but low sensitivity (i.e., less than 0.95), 
appears to be a common problem in AHDs. Data sources that have been used to validate 
administrative databases include medical records, patient or physician surveys, and clinical 
laboratory test results
6,36-38
. For example, Rector et al.
3
 investigated the validity of diagnosis 
codes for identifying cases of hypertension, heart failure, chronic lung disease, arthritis, 
glaucoma, and diabetes using survey data as the gold standard. For all six conditions the 
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specificities of diagnosis-based case-detection algorithms were greater than 0.95 but sensitivities 
were rarely higher than 0.90. A study about hypertension found that a diagnosis-based case-
detection algorithm had a sensitivity of 0.73 and a specificity of 0.95 when medical records were 
used as the gold standard and a sensitivity of 0.64 and a specificity of 0.94 when self-reported 
survey data were used as the gold standard
6
. Osteoarthritis is another disease that is prone to 
misclassification in AHDs; it has been estimated that the sensitivity of diagnosis-based case- 
detection algorithms is between 0.70 and 0.80, while specificity is between 0.90 and 1.00
12
. 
Diagnoses for comorbid conditions are also prone to misclassification in AHDs. Comorbid 
conditions are co-occurring diseases that are related to the primary disease. Validation studies 
based on chart data have shown that comorbidities are likely to be underestimated in AHDs
37
. As 
well, the type of AHD that is used to ascertain comorbidities may also influence sensitivity. 
Klabunde et al. demonstrated that in cohorts of elderly prostate and breast cancer patients the 
proportion of patients identified with comorbid conditions increased to as much as 25 percent by 
using physician claims data to identify diagnoses instead of hospital records. The latter data 
source could detect less than 10 percent of the true comorbid conditions
39
. However, physician 
claims data were still prone to misclassification of comorbid conditions. A Canadian study that 
compared chart data and administrative data revealed that the latter generally underestimate 
individual comorbidities
37
. Another study that undertook a chart review in 817 hospitalized 
patients receiving percutaneous coronary interventions also found that administrative data tended 
to underestimate the prevalence of some comorbidity
40
. Therefore, if comorbid conditions are 
used as disease predictor variables in model-based case-detection algorithms, they may induce 
bias in the predictive model.  
The effect of error in the response variable on bias in the covariate effect estimates depends 
on the sensitivity and specificity of the observed response; when both sensitivity and specificity 
are low, the estimate of the covariate effect will be biased downward
41
. For measurement error in 
a continuous covariate, the amount of error also impacts on the performance of measurement 
error correction methods
16
. The characteristics of the measurement error or misclassification 
deserve more investigation.    
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2.3 Measurement Error Correction Methods  
Measurement error correction methods have primarily been developed for the case of 
measurement error or misclassification in model covariates
22,42-47
. For example, one approach for 
measurement error in covariates is the regression calibration (RC) model, which uses 
information from a validation dataset to analyze the association between the true and observed 
variables and then corrects the estimate of association in the main dataset
48,49
. The RC method is 
popular because it is a simple approach to use. However, it can be problematic in situations 
where the covariates have skewed distributions
50
. When the covariate is analyzed on a 
categorical scale, the RC method will result in similar estimates of the effects of covariates as the 
estimates without measurement error correction
51
.   
A second approach to address measurement error in covariates is the maximum-likelihood 
(ML) method, which maximizes the likelihood function as if the true values were observed based 
on the assumed measurement error model (i.e., Classical or Berkson model)
52-55
. Firstly, the 
likelihood function of response given the true covariates is constructed. And then depending on 
whether the error model is assumed to be Classical or Berkson, the likelihood analysis is defined 
based on the joint distribution of the response, true covariates and observed covariates. This 
method can derive reliable likelihood-based confidence intervals in nonlinear models but model 
misspecification is a serious limitation. Pepe demonstrated that the ML parameter estimates are 
not robust to misspecification of the error model
56
. As well, ML estimation of misspecified 
models have been shown to result in invalid inference
57
. 
MI methods has been investigated to correct for measurement error in covariates and 
compared with both RC and ML methods
58
.  MI and RC methods were compared for estimating 
the hazard ratios in a simulation study based on a real study about end-stage renal disease
15
. The 
variable of interest was the glomerular filtration rate (GFR), which is considered to be an error 
prone measure of renal function. In the simulation study, sensitivities of 0.7 or 0.9 and 
specificities of 0.7 or 0.9 were investigated for the GFR. The MI method produced unbiased 
estimates of the hazard ratio and had approximately correct coverage of the 95% confidence 
interval. When the sensitivity and specificity of the observed GFR was low the MI method was 
more powerful than the RC method. Other studies have shown that for validation dataset/main 
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dataset designs, the MI method results in smaller bias and similar error rates when compared to 
the ML method
58
.   
Methods for inference and estimation in the presence of an error-prone binary response 
variable have also been proposed
56,59-61
. However, most of these methods assume the covariates 
are measured without error. One exception is the method by Mallick and Gelfand; they proposed 
a Bayesian approach based on a semiparametric generalized linear model, which can 
accommodate measurement error in both the response variable and the covariates
62
. Their 
Bayesian model involves fitting three separate regression models for measurement error in the 
covariates, the response variable, and the relationship between the response variable and 
covariates. For each regression model, a semiparametric generalized linear model was introduced 
utilizing an unknown monotonic function (nonparametric links) along with parametric regression 
coefficients. However, only a Poisson regression model for the link function of the response and 
covariates was illustrated by simulation. Different link functions were specified to investigate the 
ability to modify misspecified true functions of the semiparametric models. The results 
demonstrated the large sensitivity of the method to the link function specification.    
Chakraborty and Banerjee
63
 considered bivariate regression models containing one binary 
response and one continuous response when the covariate was error prone and the binary 
response was misclassified. The covariate was assumed to follow a normal distribution with a 
Berkson error model and non-differential measurement error. The responses were generated from 
bivariate normal distribution, and the binary response was obtained by dichotomizing a 
continuous variable. A simulation study was undertaken to investigate the effects of 
measurement error and/or misclassification on the model parameter estimates based on different 
choices of the additive variance of the observed covariate and probability of misclassification. 
Four models were compared, including a naïve model (i.e., without consideration of 
measurement error and misclassification), a model incorporating classification error, a model 
incorporating measurement error, and a model incorporating both classification error and 
measurement errors. Misclassification attenuated the estimated correlation between the response 
variables, while measurement error inflated the coefficient estimates. The attenuating effect of 
measurement error in the error prone covariate on the estimated covariate coefficients became 
larger as the additive variance of the measurement error increased, when the binary response was 
9 
  
 
not misclassified. When the additive variance was 0.5, the estimate of the correlation between 
the response variables whose true value was 0.60 was estimated to be 0.73, but when the additive 
variance increased to 1.0, the estimated correlation increased to 0.80. When measurement error 
was absent, misclassification of the binary response also attenuated the coefficient estimates of 
the covariate and the bias became larger as the misclassification probability increased. For 
instance, when the probability of misclassification was 0.01 (i.e., the sensitivity and specificity 
were 0.99), the estimate of the coefficient of the covariate equaling to 1.00 was 0.73; when the 
probability of misclassification was 0.05 (i.e., the sensitivity and specificity were 0.95), the 
estimate of the coefficient of the covariate decreased to 0.55. The study demonstrated that if both 
measurement error and misclassification exist in the data, the attenuation of the estimate of the 
covariate’s coefficient became pronounced with increase in the value of the misclassification 
error rates as well as measurement error variance. The measurement errors result in attenuation 
of the estimate of the correlation between response variables, and the misclassification results in 
inflation of the estimate of the correlation between response variables.       
2.4 MI Methods 
MI methods have been used to address nonresponse in large survey datasets, such as the US 
National Health and Nutrition Examination Survey
64
, the US Survey of Consumer Finance
65
, the 
US National Health Interview Survey
66
, and the Cancer Care Outcomes Research and 
Surveillance Consortium
67
. MI methods have also been used to handle missing data in non-
survey contexts
24
. As noted in the previous section, MI methods were applied to observational 
health care outcomes data to address measurement error in binary treatment variables
60
.  
One consideration in adopting a MI method is the mechanism by which observations are 
missing. The data may be missing completely at random (MCAR), missing at random (MAR), or 
missing not at random (MNAR). If missingness of the observations does not depend on the 
actual values, regardless of whether they are missing or observed, the missing data are MCAR. 
On the other hand, if the missingness mechanism is MAR, this means that the missingness 
depends only on the observed values and not on the missing values. Under the MAR assumption, 
the missing data may depend on the data itself, but only indirectly through relationships with 
observed values. If the missingness mechanism is MNAR, missingness depends on the missing 
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values
68
. Research has demonstrated that even if the missingness mechanism is MNAR, the MI 
method will not always result in biased regression parameter estimates and standard errors
69
; 
however the size of the bias is dependent on the amount of missing data. Moreover, some studies 
have applied the MAR missingness mechanism as a plausible assumption 
60,70
. For the 
validation/main datasets design, the sampling frame of the validation subjects determines the 
missingness mechanism. If the individuals in the validation dataset are a random sample from the 
population, the missing values in the main dataset are MCAR. If individuals’ presence in the 
validation dataset is dependent on variables that are observed in both the validation and main 
datasets, the missing values in the main dataset are MAR. And if individuals’ presence in the 
validation dataset is dependent on variables that are not observed (i.e., missing) in the main 
dataset, the missing values in the main dataset are MNAR.   
Yucel and Zaslavsky
71
 applied imputation methods for binary treatment variables with 
measurement error in administrative data.  In their study, the administrative database was a 
cancer registry that collected data on treatment and survival for all incident colorectal cancer 
cases in California. The validation dataset was a dataset collected by surveying physicians or 
reviewing office records, which covered 74% patients. The MAR missingness mechanism was 
assumed, because treatment information was obtained less often from physicians’ surveys or 
office records for patients 75 years of age and older, unmarried patients, nonrural patients, those 
in low-volume hospitals or hospitals with radiation facilities, and those living in San 
Francisco/Oakland than in San Jose/Monterey or Sacramento.    
MI accounts for the uncertainty introduced by the imputation process and reduces potential 
bias due to systematic differences between the observed and missing data
68
. Compared with a 
single imputation approach, MI results in accurate estimates of the confidence intervals. Messer 
and Natarajan studied the ML, MI, and RC methods for adjustment in the covariates and 
suggested that MI methods can be an appropriate approach to impute unobserved values of both 
the response and covariates
58
.  
Rubin proposed MI based on Bayesian theory
24
. MI methods derived from a Frequentist 
approach have also been evaluated
72
. The Bayesian and Frequentist approaches handle 
uncertainty in model parameters differently. Under the Bayesian approach, the model parameters 
are treated as random variables whose prior distributions can be specified based on experience 
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and other sources. The likelihood and prior distribution determine the posterior distribution of 
the parameter
73
. MI methods under the Bayesian approach draw values of the unobserved 
variables by sampling from the posterior distribution, given the observed values and the other 
parameters
23
. Under the Frequentist approach, the values of the parameters are fixed and the MI 
method is used to obtain multiple draws of the plausible values from the asymptotic distribution 
of the parameters as estimated from a predictive model. Thus, when imputing the unobserved 
true covariate, the Bayesian approach conditions on the response as well as the observed 
measurement of the true covariate(s), while the Frequentist approach only depends on the 
observed measurement. In addition, the Frequentist inference is based on asymptotic 
approximations; the Bayesian approach converges stochastically to a posterior distribution that is 
exact, regardless of sample size
72
. To implement MI in the Bayesian approach when the 
likelihood function is complicated to derive, the sampling-based Markov Chain Monte Carlo 
(MCMC) method has been proposed
23
. A Markov chain is a sequence of random variables in 
which each element’s value depends only on the value of the previous element and the chain 
converges to a stationary posterior distribution.   
In addition, the size of the validation dataset as a proportion of the entire population will 
have an influence on inference using the MI method. The MI method proposed by Rubin works 
best if the missingness rate is less than forty percent. Consequently, the efficiency and 
consistency of MI methods when the missingness rate is higher than this requires further 
consideration. The relative efficiency of an estimate based on K imputations compared to an 
estimate based on an infinite number of imputations is (  
 
 
)
  
, where λ is the rate of missing 
data
68
. As few as three to 10 imputations will produce efficient results
74
. However, one 
simulation study about a simple regression model showed that when   is held constant, as the 
number of imputations increased from three to 100 the values of mean squared error (MSE) and 
standard error (SE) decreased and power increased. For instance, when the proportion of missing 
information was 0.30 the MSE, SE and power for three imputations were 1.31, 0.04, and 0.69, 
respectively. In contrast, the MSE, SE and power based on 100 imputations were 1.20, 0.04, and 
0.79, respectively. When the fraction of missing information was 0.90, the MSE, SE and power 
for K = 3 were 1.67, 0.04, and 0.39, while the corresponding values for 100 imputations were 
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1.21, 0.04, and 0.78, respectively. Consequently, the authors recommended using 40 imputations 
when λ = 0.70 and 100 imputations when λ = 0.9075.  
2.5 MI in Practice  
Software packages that implement MI methods include SAS, S-PLUS, Stata, R and MICE 
(Multivariate Imputation by Chained Equations). In SAS, PROC MI and PROC MIANALYZE 
are available to implement MI methods. However, most MI methods in SAS are available for 
monotone missing pattern data, when the pattern of missingness is arbitrary, only continuous 
variables can be imputed using PROC MI
76
. There are also a few SAS macros for MI using 
sequences of regression models or distance-aided selection of donors
77
. The MICE method has 
also been implemented as a S-PLUS library and an R package as well as in Stata. Overall, these 
programs provide an easy to use environment for applying MI. However, the restrictions of 
assumptions still limit the application of MI in specific study
78
.  
2.6 Summary of Literature Review 
Previous research has demonstrated that measurement error exists in chronic disease 
outcomes and comorbidities defined from diagnosis codes in AHDs. This measurement error is 
primarily due to low sensitivity of the diagnoses in AHDs. While a few procedures have been 
proposed to address measurement error in AHDs, developing a predictive model that uses MI 
methods to impute disease status is appealing because this approach should be relatively 
straightforward to implement and interpret. MI methods based on Frequentist or Bayesian 
approaches have been proposed and applied in real datasets, but the performance of both 
approaches has not been compared in previous research. Factors that have been shown to directly 
or indirectly influence the performance of the MI method for measurement error correction have 
been investigated, but few studies have simultaneously investigated these factors when both the 
response variable and the covariates are error prone. Factors that have been investigated in 
previous research that may influence the performance of MI measurement error correction 
methods included the sensitivity of the error-prone response variable, the amount of 
measurement error in the covariates of the predictive model, the size of the validation dataset and 
the number of imputations.   
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CHAPTER 3. STUDY METHODS 
This chapter describes the MI methods using Frequentist and Bayesian logistic regression 
model as predictive model for a main study/validation study design. Using the MI method, K >1 
complete datasets are obtained by replacing the missing true values with K simulated values 
obtained from independent draws from a predictive model. The estimates of the interested 
parameters from K complete datasets are combined by averaging. The variability of the estimates 
includes both within-imputation and between-imputation variance. The following sections 
describe the characteristics of the validation and main datasets, measurement 
error/misclassification models, predictive models, inference of MI and the underlying 
assumptions of the models. 
3.1 Validation and Main Dataset Characteristics 
Let n denote the number of subjects in the validation dataset and N denote the number of 
subjects in the entire dataset. The number of subjects in the main dataset, in which the 
information on true disease status is missing, is N – n. The error-free measure of disease status 
(i.e., presence/absence) is denoted by  . Note that   is not observed in the main dataset but it is 
observed in the validation dataset. The observed, error-prone measure of disease status, denoted 
by  , is observed in both the validation and main datasets. Specificity and sensitivity of the 
observed disease status are defined as,               and              , 
respectively. In this study, we consider the case in which the observed response is under-reported 
(i.e., sensitivity < 1.0) but there are no false positives (i.e., specificity is equal to 1.0).  
The disease model considered in this study is one in which two covariates are associated 
with the probability of disease presence in the validation and main datasets
42,43,48
. These are a 
continuous covariate denoted by    and a categorical (i.e., binary) covariate denoted by   . The 
covariate    is assumed to follow a normal distribution with parameters    and   
  denoting the 
mean and variance, respectively. The covariate    is assumed to follow a binomial distribution 
with parameters B=1 and    denoting the number of trials (equals to 1) and the probability of 
success, respectively. We assume that    and    are independent. Formally, the disease model is 
given by 
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,              (3-1) 
for         where             
T
 is the vector of regression parameters and 
T
 denotes the 
transpose operator.  
Let   and   denote the error-prone measures of the true covariates    and   , 
respectively. As well, an indicator variable,   , indicates whether the jth subject is in the 
validation dataset or main dataset. If      the j
th
 subject is in the validation dataset and if 
     the j
th
 subject is in the main dataset. To summarize, the validation dataset contains Y,  , 
  ,   ,   and  , while the main dataset only contains  ,   and   (see Figure 3-1). Missing 
values are denoted by ‘.’. 
 
 
Validation 
Dataset 
                  
1 1 1 12 12 1 0 
1 1 0 16 14 0 1 
1 0 0 9 10 1 1 
1 1 0 5 6 0 0 
1 0 0 20 21 1 0 
 
Main  
Dataset 
0 . 1 . 23 . 1 
0 . 0 . 6 . 0 
0 . 0 . 15 . 1 
0 . 0 . 17 . 1 
0 . 1 . 13 . 0 
… … … … … … … 
Figure 3-1 An illustration of the validation dataset/main dataset design 
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3.2 Measurement Error and Misclassification in Disease Predictors       
Measurement error under a continuous covariate    can be considered under both the 
Classical and Berkson models
46,79
. As defined previously, the Classical model is        , 
where    is uncorrelated with    that is           . In this model   is an unbiased 
measurement of   . The structure of    is homoscedastic. The Berkson model is defined as 
        , where    is uncorrelated with  , that is           .  
Let         denote the marginal distribution of   . The Classical model can be incorporated 
into a model to predict    via Bayes theorem, 
             
                    
∫                       
                              (3-2) 
where               is the density of   given   . Having         the density of   , equation 
(3-2) can transform the Classical model into a predictive model. Thus the predictive model for 
the continuous covariate    is 
                            ,                                 (3-3) 
where          ,         
T
 and         
   which is independent of    and  . The 
function                  is the calibration function of true continuous covariate conditional on 
the measured continuous covariate and can be used to predict the true value of the continuous 
covariate. The predictive model for the binary covariate is,  
                 
           
             
                                          (3-4) 
where          
T
 is the vector of parameters reflecting the association between    and  . 
The function                  is the calibration function of true binary covariate conditional on 
the measured binary covariate and can be used to predict the true value of the binary covariate.    
3.3 Development of the Predictive Model 
In this study, a logistic regression model is used to build a predictive model for disease 
status in the validation dataset. Two models were considered: 
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3.3.1 Scenario 1: Misclassification of Observed Disease Status is Independent of Disease 
Predictors 
The first scenario is one in which misclassification of the observed disease status is assumed 
to be independent of the disease predictors in the validation dataset. In this case, true disease 
status is predicted from observed disease status only. Thus, the predictive model is 
                      ,                                                 (3-5) 
where       . This predictive model is fitted to the validation dataset to estimate the 
parameters          
T
. The predictive model for the main dataset is  
                ̂   ̂                                                     (3-6) 
where          . Using equation (3-6), the probability of being a disease case is estimated. 
This probability becomes the parameter for an observation sampled from the Bernoulli 
distribution. Specifically, Bernoulli (          ) generates a binary response for the  th 
subject in the main dataset.   
To estimate the parameters of this logistic regression model, the most widely used method 
is the iterative Newton-Raphson algorithm, 
                                                                  (3-7) 
where      is the parameter vector for the     iteration,            ̂  , and                          
        ̂    ̂   with  ̂  
 
            
.   
When the sample size or the total Fisher information is small, there is the potential for bias 
in the maximum likelihood estimates. The amount of bias in the estimated parameters for linear 
logistic models, as proposed by Cordeiro and McCullagh
80
, is 
                                                                        (3-8) 
where                      ̂       and         ̂    ̂  . Therefore, a bias-
corrected estimate, was proposed by the authors, and is given by  ̂   ̂   .  
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In studies that validate AHDs, the validation dataset is often small
81,82
, therefore we 
compared both the bias-corrected estimates and uncorrected estimates for the Frequentist 
approach. Using the bias-reduced estimates  ̂  and covariance matrix C( ̂ ), multiple values of 
the parameters  ̃              are drawn from its asymptotic normal posterior distribution 
 ̃   ~N[ ̂ , C( ̂ )]. The corresponding values of the probability     
       ̃     are obtained 
from equation 6 and multiple imputed values of the true response are drawn from the Bernoulli 
distribution   
   
           (  
   |   ̃   ) .  
For the Bayesian approach, we used a previously proposed logistic regression model
83
. 
Specifically, the authors used a prior in the conjugate form as the likelihood function, so the 
posterior had the same form as the likelihood as well. Then the value of the interested parameter 
that maximized the posterior was the maximum posterior estimator. Generally, the Markov chain 
Monte Carlo (MCMC) algorithms such as the Metropolis-Hastings and the Gibbs sampler can be 
implemented to sample the parameters of interest from their posterior distributions
84
. The 
predictive model in equation (3-6) was adopted. The parameters          
T
 were treated as 
random variables. Non-informative priors were chosen; these follow a normal distribution with a 
mean of zero and large variance. Multiple values of the parameters  ̂  (       ) were 
randomly drawn from the posterior distribution and used to compute the disease probability, that 
is  (  
   |   ̂   ). Subsequently, multiple imputed values of the true response were drawn from 
the Bernoulli distribution   
   
              
       ̂     .   
3.3.2 Scenario 2: Misclassification of Observed Disease Status is Dependent on Disease 
Predictors 
For this scenario, the misclassification of the observed disease status is conditional on one 
or more disease predictor variables. Under the Frequentist approach, a predictive logistic model 
was developed in the validation dataset using two covariates, one of which was binary and one of 
which was continuous, and the observed disease status. From equation (3-3) and equation (3-4), 
the bias-reduced parameters ( ̂  and  ̂ ) and the covariance matrixes (   ̂   and    ̂  ) were 
estimated. Multiple values of the parameters of each model were drawn from the asymptotic 
normal distribution N[ ̂ , C( ̂ )] and N[ ̂ , C( ̂ )]. The multiple predicted values of the true 
covariates were obtained using the equations  ̂  
   
  ̂ 
   
  ̂ 
   
    and 
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 ̂  
   
              ̂  
         ̂
      with  ( ̂  
   |     ̂
   )  
   ̂ 
   
  ̂ 
   
    
     ̂ 
   
  ̂ 
   
    
, where   
     . The predictive model of the true response fitted in the validation dataset to estimate the 
parameter vector                
T
 was 
                                        .             (3-9) 
The model to predict the missing true response in the main dataset is 
       (    |  ̂    ̂  )   ̂   ̂  ̂    ̂  ̂    ̂    .     (3-10) 
From equation (3-9) the bias-reduced estimates were used to produce the estimates  ̂  and 
   ̂  . Multiple values of  ̂  were drawn from the asymptotic normal distribution ~N[ ̂ , 
C( ̂ )]. To impute Y in the main dataset, we apply  ̂  and estimated covariates  ̂  and  ̂  to 
equation (3-10) to obtain        (  
   
  |  ̂    ̂  )   ̂   ̂  ̂    ̂  ̂    ̂   . The 
multiple imputed values of the missing true response in the main dataset    were drawn from the 
Bernoulli distribution,   
   
         ( (  
   |   ̃   )).  
Three different predictive models were considered. The predictive model defined in 
equation (3-9) was compared with two other predictive models:   
                           ̂      ̂                           (3-11) 
                            .                                     (3-12) 
These model comparisons were done because in practice, different variables might be 
selected as covariates in the predictive model.  
3.4 Prevalence and Variance Estimation 
Using the imputed disease status values computed in the previous section, the estimated 
prevalence for the     dataset is  ̂
    
∑   ∑  
   
 
. For the MI method, the final estimated 
prevalence for the entire population is  ̂  
 
 
∑  ̂       , which reflects the uncertainty caused by 
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the missingness of true values. The total variability, TK, includes within-imputation variance 
( ̅ ) and between-imputation variance (BK), that is,  
 ̅  
 
 
∑   
 
                                                                       (3-13) 
where      ( ̂
   )     (
∑   ∑  
   
 
)  
 
  
∑       
           
 
  
∑  (  
   )       
   
        , 
   
 
   
∑   ̂     ̂                                                          (3-14) 
    ̅  
   
 
  .                                                               (3-15)  
With the final estimated prevalence  ̂ and the total variability TK, the 95% confidence interval 
was calculated based on asymptotic normal distribution.  
 
  
20 
  
 
CHAPTER 4. SIMULATION STUDY 
A Monte Carlo simulation study was undertaken to investigate the MI methods for 
measurement error correction. The parameters that were manipulated and investigated in the 
Monte Carlo study include sensitivity of the observed disease status, amount of error in the 
covariates, size of the validation dataset, and numbers of imputations. Table 4-1 summarizes the 
conditions that were investigated for each of these parameters. The mechanism by which 
observations were missing, including MCAR, MAR and MNAR conditions were also examined. 
Table 4-1: Parameters of the simulation study 
Sensitivity of 
observed 
disease status 
 
Measurement 
error in   
Misclassification 
in   
Size of 
validation 
dataset 
Number of 
imputations 
0.60 Var(  )=1 or 2 
SN=SP=0.7 or 
SN=SP=0.9 
 
0.05, 0.20, 
0.35 
 
3, 5, 10, 15, 
20, 40 
0.75 Var(  )=1 or 2 
SN=SP=0.7 or 
SN=SP=0.9 
0.90 Var(  )=1 or 2 
SN=SP=0.7 or 
SN=SP=0.9 
Note: SN denotes sensitivity and SP denotes specificity 
The Monte Carlo study was conducted using SAS/IML (Interactive Matrix Language) 
software version 9.2. The simulation program is included in Appendix D. The RANGEN 
procedure was used to generate random numbers from the specified distributions. A total of 
 =500 replications was conducted for each combination of conditions. A population size of 
 =10,000 was used to implement the models.  
The data were generated using the disease model defined in the previous chapter. The 
continuous covariate, X1 was generated from the standard normal distribution (i.e.,         and 
the binary covariate, X2 was generated from the binomial distribution (i.e., BIN(N,   )). These 
two covariates were generated independently. The true response was generated based on the 
disease model (equation 1) using specified values of the regression coefficients   ,    and   . 
Then the Bernoulli random variable with probability P was generated as 1 or 0, where 1 denotes 
disease presence and 0 denotes disease absence.  
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The coefficients    and    denote the strength of association between   ,    and the true 
response  . The values of these coefficients were selected based on the odds ratio, which is 
obtained by exponentiation of the regression coefficient. The choice of          corresponds 
to an odds ratio of 1.3 while          corresponds to an odds ratio of 2.0 between the 10
th
 and 
the 90
th
 percentile of the standard normal covariate. The choice of           corresponds to 
an odds ratio of 0.5 while          produces an odds ratio of 2.0 between 0 and 1 of the 
Bernoulli distributed covariate. These odds ratios are realistic for epidemiological studies about 
chronic disease
85-87
. We specified          ,          and           to generate the 
data has prevalence of the true response is 0.05, because of the low prevalence of chronic disease 
in the population.  
The methods to generate the observed response are different for the two scenarios of the 
sensitivity of the observed response. For Scenario 1, under-reporting is independent of the 
covariates, that is, when     the probability of     is randomly generated from the 
Bernoulli distribution with     the sensitivity of the response variable, as the parameter of this 
distribution. Values for    from 0.6 to 0.9 in increments of 0.15 were considered. For Scenario 2, 
under-reporting depends on the covariates, that is when     the probability of     was 
generated based on the association with the model covariates. By specifying the coefficients of 
the generation model for observed disease status, the observed response also had sensitivity from 
0.6 to 0.9 in increments of 0.15.  
For Scenario 2,   was generated by adding the additive variance as Classical error model
88
. 
Specifically, the additive variance was generated from a normal distribution with variance of 1 
(i.e., N(0,1)) or variance of 2 (i.e., N(0,2)). And the measurement error of   was assumed non-
differential. The observed binary covariate was generated by manipulating values of sensitivity 
and specificity for two conditions. In Condition 1, the sensitivity and specificity of the 
mismeasured binary covariate were equal to 0.7. In Condition 2, both the sensitivity and 
specificity were equal to 0.9. Specifying the coefficients of the true disease predictors generated 
the observed disease status with sensitivity from 0.6 to 0.9 in increments of 0.15, because the 
misclassification of the observed disease status is dependent on the true values of the disease 
predictors.  
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The mechanisms of the missingness of true response were also considered in the study 
design. If V, the indicator of the validation dataset, is a random variable then the missing 
mechanism is MCAR. If V is dependent on the observed response not on the missing true 
response then the missing mechanism is MAR. And if V is dependent on the missing true 
response then the missing mechanism is MNAR.  
In terms of the size of the validation dataset, we considered cases where it was a fixed 
proportion of the entire dataset: 0.05N, 0.20N and 0.35N. The number of imputations took on 
values of 3, 5, 10, 15, 20 and 40
15
, in keeping with previous research. 
As for the Bayesian logistic regression, the MCMC procedure, which is available in SAS 
9.2 was adopted. It uses a random walk Metropolis algorithm to simulate samples from the 
specified logistic regression model
89
. A total of 21,000 iterations were conducted in the 
simulation loop of MCMC procedure, and the first 1000 iterations were burn-in iterations. Thus, 
the last 20,000 iterations, with the thinning rate of 100, were saved as posterior samples. That 
means every 100
th
 simulation sample of the 20,000 iterations was kept and the rest were 
discarded, which results in 200 posterior samples. The posterior statistics and diagnostics such as 
MCSE/SD (the Monte Carlo standard errors of each parameter relative to the posterior standard 
deviations) and autocorrelation were calculated using the thinned posterior samples.  
Bias, relative bias, RMSE and coverage were used to evaluate the performance of the 
models,  
     
 
 
∑  
 
 
∑   ̂     
 
    
 
   ,                                      (4-1) 
              
    
               
 ,                                          (4-2)                      
                  ,                                                   (4-3) 
where  is the number of replications,   is the number of imputations, the variance is the total 
variability as defined in equation (3-15), and  ̂   is the estimate of prevalence in the th 
replicated dataset and  th imputation. To put the measure on the same scale as the prevalence, 
we report the square root of the MSE (RMSE). Coverage was calculated as the proportion of the 
simulations in which the 95% confidence intervals covered the true parameter value.   
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CHAPTER 5. RESULTS  
5.1 Scenario 1: Misclassification of Observed Disease Status is Independent of Disease 
Predictors  
Table 5-1: Relative bias, RMSE and 95% confidence interval coverage when the size of the 
validation dataset is 0.05N 
Sensitivity of 
observed disease 
status 
Missing 
mechanism 
Bayesian Frequentist Frequentist 
(Bias Corrected) 
  Relative Bias (%) 
0.60 MCAR -37.13 -26.14 -0.32 
 MAR -37.69 -28.34 -6.61 
 MNAR -39.69 -23.57 -32.03 
0.75 MCAR -23.53 -31.36 -0.69 
 MAR -23.75 -33.66 -6.86 
 MNAR -25.01 62.97 -23.16 
0.90 MCAR -9.53 37.61 -0.31 
 MAR -9.81 27.18 -6.99 
 MNAR -10.33 310.49 -13.05 
  RMSE 
0.60 MCAR 0.0185 0.0145 0.0031 
 MAR 0.0188 0.0155 0.0048 
 MNAR 0.0197 0.0323 0.0162 
0.75 MCAR 0.0117 0.0198 0.0027 
 MAR 0.0118 0.0192 0.0048 
 MNAR 0.0125 0.0678 0.0120 
0.90 MCAR 0.0047 0.0497 0.0022 
 MAR 0.0049 0.0466 0.0048 
 MNAR 0.0052 0.1903 0.0072 
  Coverage 
0.60 MCAR 0.00 0.00 0.53 
 MAR 0.00 0.00 0.50 
 MNAR 0.00 0.00 0.05 
0.75 MCAR 0.00 0.41 0.53 
 MAR 0.00 0.00 0.50 
 MNAR 0.00 0.00 0.10 
0.90 MCAR 0.00 0.49 0.60 
 MAR 0.01 0.00 0.50 
 MNAR 0.00 0.01 0.26 
Note: RMSE = root mean squared error; MCAR is missing completely at random; MAR is 
missing at random; MNAR is missing not at random 
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Results for Scenario 1 are reported first. The simulation results are described for each of the 
measures of relative bias, RMSE, and coverage probability. Tables 5-1 to 5-3 present the results 
for the three different sizes of the validation dataset. 
When the size of the validation dataset was 0.05 N (Table 5-1), the Bayesian MI model 
resulted in relative bias and RMSE values for the MCAR condition that were smaller than for the 
MAR and MNAR conditions. For the Frequentist MI model without bias correction, the relative 
bias and RMSE were the largest when the sensitivity was 0.90 under the MNAR condition. The 
Frequentist MI model with bias correction had substantially smaller relative bias for the MAR 
condition (70.02%) than for the MNAR condition. When the sensitivity of the observed disease 
status was 0.75 or 0.90, the Bayesian MI model had smaller relative bias than the Frequentist 
model without bias correction. However, the Frequentist model without bias correction had 
better coverage when the missingness mechanism was MCAR and the sensitivity was 0.75 or 
0.90. In this situation, the Frequentist model with bias correction had the smallest relative bias; 
absolute values were less than 1.00% under the MCAR condition and less than 7.00% under the 
MAR condition. The 95% confidence intervals for the Frequentist model with bias correction 
had coverage probability greater than 0.50 if the MAR assumption was not violated. As for the 
effect of the sensitivity of the observed disease status, the results revealed that different methods 
behaved differently as the sensitivity increased. For the Bayesian model, the relative bias and 
RMSE became smaller when the sensitivity increased. For the Frequentist model with bias 
correction, only under the MNAR condition did the relative bias and RMSE decrease with 
increasing sensitivity.  
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Table 5-2: Relative bias, RMSE and 95% confidence interval coverage when the size of the 
validation dataset is 0.20  
Sensitivity of 
observed disease 
status 
Missing 
mechanism 
Bayesian Frequentist Frequentist 
(Bias Corrected) 
  Relative Bias (%) 
0.60 MCAR -31.32 -23.36 -0.33 
 MAR -31.18 -27.80 -2.43 
 MNAR -37.26 -53.61 -28.73 
0.75 MCAR -19.66 -29.02 -0.06 
 MAR -19.67 -34.72 -2.49 
 MNAR -23.36 -50.76 -18.97 
0.90 MCAR -7.98 -35.12 -0.25 
 MAR -7.99 -41.68 -2.55 
 MNAR -9.42 -24.07 -9.07 
  RMSE 
0.60 MCAR 0.0156 0.0126 0.0018 
 MAR 0.0155 0.0150 0.0023 
 MNAR 0.0185 0.0273 0.0143 
0.75 MCAR 0.0098 0.0156 0.0015 
 MAR 0.0098 0.0186 0.0021 
 MNAR 0.0116 0.0263 0.0095 
0.90 MCAR 0.0040 0.0189 0.0011 
 MAR 0.0040 0.0223 0.0019 
 MNAR 0.0047 0.0287 0.0047 
  Coverage 
0.60 MCAR 0.00 0.00 0.72 
 MAR 0.00 0.00 0.71 
 MNAR 0.00 0.00 0.00 
0.75 MCAR 0.00 0.50 0.73 
 MAR 0.00 0.00 0.69 
 MNAR 0.00 0.00 0.01 
0.90 MCAR 0.00 0.51 0.76 
 MAR 0.00 0.00 0.66 
 MNAR 0.00 0.00 0.06 
Note: RMSE = root mean squared error; MCAR is missing completely at random; MAR is 
missing at random; MNAR is missing not at random 
 
When the size of the validation dataset was 0.20N (Table 5-2), the results followed similar 
trend to those when the size of the validation dataset was 0.05 . However, the RMSE values for 
all MI models were smaller than when the size of the validation dataset was 0.05N. And in this 
situation, measures for each model under MCAR and MAR conditions were similar, which were 
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quite different from the measures for the model under MNAR condition. The Bayesian MI model 
had smaller relative bias than the Frequentist MI model except when the sensitivity was 0.60 and 
under MCAR and MAR. Under MCAR and when the sensitivity was 0.75 and 0.90, the 
Frequentist model without bias correction had coverage 0.50 and 0.51 much better than other 
conditions for this model.  The Frequentist model with bias correction had the best performance 
in terms of coverage probability and absolute values of relative bias, as long as the missingness 
mechanism was not MNAR. When the sensitivity increased, the Bayesian MI model had 
decreasing relative bias and RMSE, but the coverage was unchanged. With the sensitivity 
increasing, the relative bias and RMSE of the Frequentist MI model increased under MCAR and 
MAR conditions, and the relative bias decreased under MNAR condition. Under MCAR and 
MAR conditions, the Frequentist MI model with bias correction had no trend with the sensitivity 
increasing. Under MNAR, the Frequentist MI model had smaller (33.97%) relative bias when the 
sensitivity was 0.75 than the relative bias when the sensitivity was 0.60, and had smaller 
(52.19%) relative bias when the sensitivity was 0.90 than the relative bias when the sensitivity 
was 0.75.     
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Table 5-3: Relative bias, RMSE and 95% confidence interval coverage when the size of the 
validation dataset is 0.35  
Sensitivity of 
observed disease 
status 
Missing 
mechanism 
Bayesian Frequentist Frequentist 
(Bias Corrected) 
  Relative Bias (%) 
0.60 MCAR -25.45 -19.17 -0.14 
 MAR -25.28 -25.94 -1.47 
 MNAR -35.19 -52.58 -27.89 
0.75 MCAR -16.02 -24.02 -0.10 
 MAR -15.82 -32.30 -1.45 
 MNAR -21.99 -48.96 -17.96 
0.90 MCAR -6.50 -28.42 -0.17 
 MAR -6.41 -39.00 -1.45 
 MNAR -8.84 -44.41 -8.06 
  RMSE 
0.60 MCAR 0.0127 0.0104 0.0016 
 MAR 0.0126 0.0140 0.0019 
 MNAR 0.0175 0.0266 0.0139 
0.75 MCAR 0.0080 0.0129 0.0013 
 MAR 0.0079 0.0173 0.0016 
 MNAR 0.0109 0.0252 0.0090 
0.90 MCAR 0.0032 0.0152 0.0009 
 MAR 0.0032 0.0208 0.0013 
 MNAR 0.0044 0.0237 0.0041 
  Coverage 
0.60 MCAR 0.00 0.49 0.87 
 MAR 0.00 0.00 0.84 
 MNAR 0.00 0.00 0.00 
0.75 MCAR 0.00 0.50 0.87 
 MAR 0.00 0.00 0.84 
 MNAR 0.00 0.00 0.00 
0.90 MCAR 0.00 0.53 0.87 
 MAR 0.00 0.00 0.80 
 MNAR 0.00 0.00 0.02 
Note: RMSE = root mean squared error; MCAR is missing completely at random; MAR is 
missing at random; MNAR is missing not at random 
 
Similarly, as Table 5-3 reveals when the size of the validation dataset was 0.35N, the 
Frequentist MI model with bias correction had the smallest relative bias and RMSE even when 
the missingness mechanism was MNAR. When the missingness mechanism was MCAR and 
MAR the coverage of the Frequentist MI model with bias correction was greater than 0.80. 
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Under MCAR, the Frequentist MI model without bias correction had coverage of 0.49, 0.50 and 
0.53 when the sensitivity was 0.60, 0.75 and 0.90, respectively. Under MAR and MNAR, the 
Frequentist MI model without bias correction had low coverage. Other than when the sensitivity 
was 0.60 and under MCAR, the Bayesian MI model had smaller relative bias than the 
Frequentist MI model without bias correction. The relative bias and RMSE of the Bayesian MI 
model decreased with increasing sensitivity of the observed disease status under all of the three 
missingness mechanisms. Under the MNAR condition, the Frequentist model with and without 
bias correction had smaller relative bias and RMSE when sensitivity was larger.  
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Table 5-4: Relative bias, RMSE and 95% confidence interval coverage with the size of the 
validation dataset increasing 
Missing 
mechanism 
Size of the 
validation 
dataset 
Bayesian Frequentist Frequentist 
(Bias Corrected) 
  Relative Bias (%) 
MCAR 0.05  -23.40 -6.63 -0.44 
 0.20  -19.65 -29.17 -0.22 
 0.35  -15.99 -23.87 -0.14 
MAR 0.05  -23.75 -11.61 -6.82 
 0.20  -19.61 -34.73 -2.59 
 0.35  -15.84 -32.41 -1.46 
MNAR 0.05  -25.01 116.63 -22.75 
 0.20  -23.35 -42.81 -18.92 
 0.35  -22.01 -48.65 -17.97 
  RMSE 
MCAR 0.05  0.0116 0.0280 0.0027 
 0.20  0.0098 0.0157 0.0015 
 0.35  0.0079 0.0128 0.0013 
MAR 0.05  0.0118 0.0271 0.0048 
 0.20  0.0097 0.0186 0.0021 
 0.35  0.0079 0.0174 0.0016 
MNAR 0.05  0.0124 0.0968 0.0118 
 0.20  0.0116 0.0274 0.0095 
 0.35  0.0109 0.0252 0.0090 
  Coverage 
MCAR 0.05  0.00 0.30 0.55 
 0.20  0.00 0.34 0.74 
 0.35  0.00 0.51 0.87 
MAR 0.05  0.01 0.00 0.50 
 0.20  0.00 0.00 0.69 
 0.35  0.00 0.00 0.83 
MNAR 0.05  0.00 0.00 0.13 
 0.20  0.00 0.00 0.02 
 0.35  0.00 0.00 0.01 
Note: MCAR is missing completely at random; MAR is missing at random; MNAR is missing 
not at random 
To assess the effect of the size of the validation dataset, the table above displays the average 
values of relative bias, RMSE, and coverage over the imputations and sensitivities. The Bayesian 
MI model did not result in a change in the coverage probability as the size of the validation 
dataset increased regardless the missingness mechanisms. The relative bias and RMSE of the 
Bayesian MI model decreased as the size of the validation dataset increased under all three 
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missingness mechanisms. However, the coverage probability of the Frequentist MI model 
without bias correction increased as the size of the validation dataset increased under the MCAR 
condition. When the size of the validation dataset was 0.35 , the coverage was 0.51, which was 
much more (70.00%) than the coverage when the size of the validation dataset was 0.05 .  For 
the Frequentist MI model with bias correction, under the MCAR condition, the average coverage 
when the size of the validation dataset was 0.35  was 17.57% greater than when it was 0.20N. It 
was also 34.55% when the size of the validation dataset was 0.20N than when it was 0.05 . 
Under the MAR condition, the Frequentist MI model with bias correction had better coverage 
when the size of the validation dataset was larger.     
Based on the results in the tables, the Frequentist MI model with bias correction performed 
better than other methods. So we further explore this model, showing how the prevalence 
estimates and the standard errors of the prevalence estimates vary with changes in the size of the 
validation dataset and the number of imputations.   
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Figure 5-1Prevalence estimates for the Frequentist MI model with bias correction when the 
missingness mechanism is MCAR and sensitivity is 0.60  
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Figure 5-1 contains box and whisker plots for the prevalence estimates under the MCAR 
condition for different sizes of the validation datset when the true population prevalence was 
0.05. The estimates were very close to 0.05 regardless of the number of imputations. As panel A 
reveals, prevalence estimates ranged from 0.03 to 0.07. When the size of the validation dataset 
was 0.20  and 0.35 ,  the prevalence estimates ranged from 0.04 to 0.06. The trends of the 
prevalence estimates for Bayesian MI model and Frequentist MI model were parallel as the trend 
shown in Figure 5-1 for Frequentist MI model with bias correction.  
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Figure 5-2 Standard error of prevalence estimate for the Frequentist MI model with bias 
correction when the missingness mechanism is MCAR and sensitivity is 0.60  
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Figure 5-2 contains box and whisker plots for the standard error values. The standard error 
decreased as the number of imputations increased. However, when the size of the validation 
dataset was 0.05N, the standard error decreased significantly (almost 50.00%) when the number 
of imputations increased from 3 to 10. As the number of imputations increased beyond 10, the 
change in the standard error was small. When the size of the valdiation dataset was 0.35N, the 
standard error decreased slightly as the number of imputations increased from 3 to 40. Holding 
constant the number of imputations,  the standard error was about one third smaller when the size 
of the validation dataset was 0.35  than when it was 0.05N.  
For other values of sensitivity, including 0.75 and 0.90, they followed the similar pattern as 
the sensitivity 0.60 in Appendix A.   
 
 
35 
  
 
 
 
 
Figure 5-3 Prevalence estimates for the Frequentist MI model with bias correction when the 
missingness mechanism is MAR and sensitivity is 0.60 
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Figure 5-3 reveals that under the MAR condition, average prevalence estimates remained 
stable as the number of imputations increased. When the size of the validation dataset was 0.05N 
the range of values was from 0.02 to 0.08, which was larger than for the MCAR condition (Panel 
A of Figure 5-1). When the size of the validation dataset was 0.35  the range of values for the 
MAR condition (Panel C of Figure 5-3) was similar to the range for the MCAR condition (Panel 
C of Figure 5-3). Under MAR, the increase of the size of the validation dataset can decrease the 
range of the prevalence estimates too. The Bayesian MI model and Frequentist MI model 
without bias correction had similar pattern as the Frequentist MI model with bias correction.  
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Figure 5-4 Standard errors of prevalence estimates for the Frequentist MI model with bias 
correction when the missingness mechanism is MAR and sensitivity is 0.60 
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Figure 5-4 presents the descriptive statistics for the standard error of the prevalence 
estimates for the MAR condition. When the size of the validation dataset was 0.05 , the range of 
values decreased from over 0.04 to slightly more than 0.01 as the number of imputations 
increased. The standard error was almost 50% smaller for ten imputations than for three 
imputations. While the size of the validation dataset was 0.20  and 0.35N, there was also a 
decrease in the size of the standard error, but the magnitude of change was smaller than for the 
0.05N condition. And the decrease of the standard error when the number of imputations beyond 
10 was minor, regardless the size of the validation dataset. When the number of imputations was 
fixed as 10, the mean of the standard error decreases as the size of the validation increased.  
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Figure 5-5 Prevalence estimates for Frequentist MI model with bias correction when the 
missingness mechanism is MNAR and sensitivity is 0.60 
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From Figure 5-5, we can see that the MNAR mechanism results in a range of prevalence 
estimates that were also stable when the number of imputations increased. And under MNAR the 
means of the prevalence estimates were negatively biased for different sizes of the validation 
dataset. In panel A, the range of prevalence estimates was from less than 0.01 to 0.05. In panel B, 
the range of prevalence estimate was from a little more than 0.02 to a little over 0.04. In panel C, 
the range of prevalence estimate was from 0.03 to a little more than 0.04. Although, increase the 
size of the validation dataset can reduce the range of the prevalence estimates but the means of 
the prevalence estimates were still biased.   
 
 
 
 
 
 
 
 
 
  
41 
  
 
 
 
 
Figure 5-6 Standard error of prevalence estimates for the Frequentist MI method with bias 
correction when the missingness mechanism is MNAR and sensitivity is 0.60 
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Figure 5-6 also demonstrates that increasing the number of imputations reduced the range 
and mean of the standard error of the prevalence estimates under the MNAR condition. When the 
size of the validation dataset was 0.05N the range of standard errors for a small number of 
imputations was large. When the size of the validation dataset was 0.35N the range of standard 
error was narrower and decreased slightly as the number of imputations increased. However, 
increasing the number of imputations to more than 10 was not efficient. The trends of the 
standard errors of prevalence estimates with the number of imputations increasing and the size of 
the validation dataset increasing under MNAR (Figure 5-6) were similar to those under MCAR 
(Figure 5-2) and MNAR (Figure 5-4).  
5.2 Scenario 2: Misclassification of Observed Disease Status is Dependent on Disease 
Predictors  
In this section, we report the results for the MI models for which when the observed disease 
status is dependent on the two predictors of true disease status. That means the probability of 
misclassification of the observed disease status was conditional on the disease predictors. As 
noted in the previous chapter, Model 1 contained observed disease status and imputed predictors 
as covariates of the predictive model, while Model 2 has imputed predictors as covariates of the 
predictive model. Finally, Model 3 has observed disease status the sole covariate of the 
predictive model. Given the results for Scenario 1, which indicated that the Frequentist MI model 
with bias correction resulted in less biased estimates of prevalence and generally small values for 
RMSE, we focused only on the Frequentist MI model with bias correction. However, for 
comparison, we have included the results for the Frequentist MI model without bias correction in 
Appendix B.  
 
43 
  
 
Table 5-5: Relative bias, RMSE and 95% confidence interval coverage when the size of the 
validation dataset is 0.05 , Frequentist MI model with bias correction 
Sensitivity of 
observed disease 
status 
Missing 
mechanism 
Model 1 Model 2 Model 3 
  Relative Bias (%) 
0.60 MCAR -0.82 -4.05 -0.47 
 MAR -6.61 -38.99 -5.78 
 MNAR -29.80 -61.02 -31.99 
0.75 MCAR 0.32 -4.13 -0.56 
 MAR -6.58 -47.74 -6.83 
 MNAR -29.80 -61.15 -22.97 
0.90 MCAR 1.38 -4.06 -0.27 
 MAR -6.67 -55.67 -7.06 
 MNAR -12.46 -61.06 -13.43 
  RMSE 
0.60 MCAR 0.0033 0.0048 0.0030 
 MAR 0.0050 0.0197 0.0046 
 MNAR 0.0152 0.0305 0.0162 
0.75 MCAR 0.0029 0.0048 0.0027 
 MAR 0.0049 0.0240 0.0048 
 MNAR 0.0109 0.0305 0.0118 
0.90 MCAR 0.0029 0.0049 0.0023 
 MAR 0.0050 0.0279 0.0048 
 MNAR 0.0073 0.0305 0.0075 
  Coverage 
0.60 MCAR 0.54 0.51 0.52 
 MAR 0.50 0.08 0.50 
 MNAR 0.07 0.01 0.04 
0.75 MCAR 0.56 0.51 0.54 
 MAR 0.52 0.03 0.50 
 MNAR 0.16 0.01 0.10 
0.90 MCAR 0.61 0.51 0.59 
 MAR 0.53 0.01 0.50 
 MNAR 0.34 0.01 0.24 
Note: Model 1 is the predictive model with the observed disease status and the imputed disease 
predictors as covariates; Model 2 is the predictive model with the imputed disease predictors as 
covariates only; Model 3 is the predictive model with the observed disease status as covariate 
only. RMSE = root mean squared error. MCAR denotes the missing completely at random 
mechanism; MAR denotes the missing at random mechanism; MNAR denotes the missing not at 
random mechanism.  
 
Table B-1 shows the values of all measures for the Frequentist MI model without bias 
correction. The values of measures of Model 1 and Model 3 were larger than those of the 
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Frequentist MI model with bias correction. For the Frequentist MI model without bias correction, 
the Model 2 had the smallest absolute value of relative bias under MCAR, and the Model 1 had 
the smallest absolute value of relative bias under MAR when the sensitivity was 0.60 and 0.75. 
There was no obviously trend of measures with sensitivity increasing for this model too.  
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Table 5-6: Relative bias, RMSE and 95% confidence interval coverage when the size of the 
validation dataset is 0.20 , Frequentist MI model with bias correction 
Sensitivity of 
observed 
disease status 
Missing 
mechanism 
Model 1 Model 2 Model 3 
  Relative Bias (%) 
0.60 MCAR -3.14 -24.20 -0.24 
 MAR -5.46 -54.04 -2.34 
 MNAR -29.15 -72.74 -28.63 
0.75 MCAR -2.10 -24.26 -0.21 
 MAR -4.56 -61.06 -2.29 
 MNAR -19.23 -72.83 -18.94 
0.90 MCAR -0.77 -24.28 -0.24 
 MAR -3.53 -67.99 -2.42 
 MNAR -9.84 -72.84 -9.32 
  RMSE 
0.60 MCAR 0.0024 0.0123 0.0018 
 MAR 0.0034 0.0269 0.0023 
 MNAR 0.0146 0.0362 0.0143 
0.75 MCAR 0.0018 0.0124 0.0015 
 MAR 0.0028 0.0304 0.0021 
 MNAR 0.0097 0.0362 0.0095 
0.90 MCAR 0.0012 0.0124 0.0011 
 MAR 0.0023 0.0339 0.0019 
 MNAR 0.0051 0.0362 0.0048 
  Coverage 
0.60 MCAR 0.65 0.06 0.73 
 MAR 0.57 0.00 0.71 
 MNAR 0.00 0.00 0.00 
0.75 MCAR 0.68 0.06 0.74 
 MAR 0.59 0.00 0.71 
 MNAR 0.01 0.00 0.01 
0.90 MCAR 0.74 0.06 0.75 
 MAR 0.59 0.00 0.67 
 MNAR 0.07 0.00 0.06 
Note: Model 1 is the predictive model with the observed disease status and the imputed disease 
predictors as covariates; Model 2 is the predictive model with the imputed disease predictors as 
covariates only; Model 3 is the predictive model with the observed disease status as covariate 
only. RMSE = root mean squared error. MCAR denotes the missing completely at random 
mechanism; MAR denotes the missing at random mechanism; MNAR denotes the missing not at 
random mechanism.  
 
Table 5-6 displays the results when the size of the validation dataset was 0.20 . The 
MNAR condition resulted in very large relative bias and the coverage became extremely small 
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even for Model 1 and Model 3. For Model 1 and Model 3, the coverage under the MAR 
condition was slightly smaller than the coverage under the MCAR condition. Model 2 performed 
badly when the size of the validation dataset was 0.20 . And in this situation, Model 3 had a 
little higher coverage probability compared with Model 1.  The RMSE for Model 1 was slightly 
larger than for Model 3, but the coverage of Model 1 was lower than that of Model 3 when the 
sensitivity was 0.60 or 0.75 under the MCAR condition. Under the MAR condition, the coverage 
of Model 1 was 16.28% less than that of Model 3. As for the effect of sensitivity of the observed 
disease status, the relative bias and RMSE of Model 1 decreased with increasing sensitivity. For 
Model 3, the relative bias and RMSE decreased with increasing sensitivity only for the MNAR 
condition. However, compared with the impact of the missingness mechanism, the impact of the 
sensitivity was not significant.  
Table B-2 (Appendix B) displays the results of the Frequentist MI model (without bias 
correction) when the size of the validation dataset was 0.20 . In this situation, Model 2 had the 
smallest relative bias and RMSE, and largest coverage compared with Model 1 and Model 3 of 
the Frequentist MI model under MCAR. The performance of Model 2 of the Frequentist MI 
approach was better than that of Model 2 of the Frequentist MI approach with bias correction. 
While the performance of Model 1 and Model 3 of the Frequentist MI approach were worse than 
the performance of Model 1 and Model 3 of the Frequentist MI approach with bias correction.  
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Table 5-7: Relative bias, RMSE and 95% confidence interval coverage when the size of the 
validation dataset is 0.35 , Frequentist MI model with bias correction 
Sensitivity of 
observed 
disease status 
Missing 
mechanism 
Model 1 Model 2 Model 3 
  Relative Bias (%) 
0.60 MCAR -2.88 -39.09 -0.12 
 MAR -4.27 -63.20  -1.45  
 MNAR -28.49 -78.48 -27.78 
0.75 MCAR -1.98 -39.06 -0.11 
 MAR -3.43 -69.06 -1.48 
 MNAR -18.49 -78.50 -18.04 
0.90 MCAR -0.82 -39.09 -0.12 
 MAR -2.50 -74.55 -1.45 
 MNAR -8.82 -78.45 -8.39 
  RMSE 
0.60 MCAR 0.0021 0.0196 0.0016 
 MAR 0.0027 0.0315 0.0019 
 MNAR 0.0142 0.0390 0.0139 
0.75 MCAR 0.0016 0.0196 0.0013 
 MAR 0.0022 0.0344 0.0016 
 MNAR 0.0093 0.0391 0.0090 
0.90 MCAR 0.0010 0.0196 0.0009 
 MAR 0.0017 0.0370 0.0013 
 MNAR 0.0045 0.0390 0.0043 
  Coverage 
0.60 MCAR 0.74 0.00 0.87 
 MAR 0.66 0.00 0.85 
 MNAR 0.00 0.00 0.00 
0.75 MCAR 0.78 0.00 0.86 
 MAR 0.67 0.00 0.84 
 MNAR 0.00 0.00 0.00 
0.90 MCAR 0.83 0.00 0.87 
 MAR 0.70 0.00 0.81 
 MNAR 0.02 0.00 0.02 
Note: Model 1 is the predictive model with the observed disease status and the imputed disease 
predictors as covariates; Model 2 is the predictive model with the imputed disease predictors as 
covariates only; Model 3 is the predictive model with the observed disease status as covariate 
only. RMSE = root mean squared error. MCAR denotes the missing completely at random 
mechanism; MAR denotes the missing at random mechanism; MNAR denotes the missing not at 
random mechanism.  
 
Table 5-7 shows that the effect of the missingness mechanism was substantial when the size 
of the validation dataset was 0.35 . Model 2 had very large relative bias and RMSE compared to 
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Model 1 and Model 3, similar to the results for the other sizes of the validation dataset. Model 3 
had slightly larger coverage probability than Model 1. Increasing the sensitivity of observed 
disease status from 0.60 to 0.90 reduced the relative bias by 71.53% under the MCAR condition, 
by 51.45% under the MAR condition, and by 69.04% under the MNAR condition for Model 1, 
while Model 3 was stable with the increasing of the sensitivity of observed disease status under 
MCAR and MAR.    
Table B-3 (Appendix B) reveals that the missingness mechanism was also substantial for 
the Frequentist MI model. For example, when the sensitivity was 0.90, the relative biases of 
Model 1 under MCAR, MAR and MNAR were -0.31%, -13.44% and 88.17%, respectively.  
From Table 5-5 to 5-7, the Model 1 and Model 3 had smaller absolute values and RMSE 
with the size of the validation dataset increasing. And the coverage of Model 1 and Model 3 
became larger when the size of the validation dataset increases only under MCAR and MAR. On 
the other hand, Model 2 had bigger absolute values of relative bias and RMSE and smaller 
coverage with the size of the validation dataset increasing. Tables in Appendix B show that the 
relative biases of all three models had no relationship with the size of the validation dataset. But 
the coverage of Model 2 significantly increased, and the coverage of Model 1 and Model 3 
slightly decreased with the size of the validation dataset enlarger.   
 
 
Table 5-8: Relative bias, RMSE and 95% confidence interval coverage for different conditions of measurement error in covariates 
when the size of the validation dataset is 0.05 , Frequentist MI model with bias correction 
 
Additive 
Variance 
Misclassification Model 1 
Relative Bias (%) RMSE Coverage 
  MCAR MAR MNAR MCAR MAR MNAR MCAR MAR MNAR 
 
1 
SN=SP=0.90 1.53 -5.03 -20.22 0.0031 0.0045 0.0107 0.58 0.55 0.21 
SN=SP=0.70 1.40 -5.48 -20.36 0.0031 0.0045 0.0108 0.58 0.54 0.20 
 
2 
SN=SP=0.90 -0.96 -8.03 -21.71 0.0030 0.0055 0.0115 0.56 0.49 0.18 
SN=SP=0.70 -0.80 -7.93 -21.76 0.0030 0.0054 0.0115 0.56 0.49 0.18 
  Model 2 
  Relative Bias (%) RMSE Coverage 
  MCAR MAR MNAR MCAR MAR MNAR MCAR MAR MNAR 
 
1 
SN=SP=0.90 -1.99 -45.78 -59.91 0.0044 0.0230 0.0299 0.53 0.05 0.01 
SN=SP=0.70 -2.01 -45.89 -60.12 0.0044 0.0231 0.0301 0.52 0.05 0.01 
 
2 
SN=SP=0.90 -6.17 -49.17 -62.19 0.0054 0.0247 0.0311 0.49 0.04 0.01 
SN=SP=0.70 -6.16 -49.03 -62.07 0.0053 0.0246 0.0310 0.50 0.04 0.01 
  Model 3 
  Relative Bias (%) RMSE Coverage 
  MCAR MAR MNAR MCAR MAR MNAR MCAR MAR MNAR 
 
1 
SN=SP=0.90 -0.55 -6.42 -22.93 0.0027 0.0047 0.0119 0.56 0.50 0.13 
SN=SP=0.70 -0.42 -6.64 -22.91 0.0027 0.0048 0.0119 0.55 0.51 0.12 
 
2 
SN=SP=0.90 -0.41 -6.68 -22.67 0.0026 0.0048 0.0118 0.55 0.50 0.13 
SN=SP=0.70 -0.35 -6.48 -22.67 0.0027 0.0047 0.0118 0.55 0.50 0.13 
 
Note: Model 1 is the predictive model with the observed disease status and the imputed disease predictors as covariates; Model 2 is the 
predictive model with the imputed disease predictors as covariates only; Model 3 is the predictive model with the observed disease 
status as covariate only. SN = sensitivity; SP = specificity. RMSE = root mean squared error. MCAR denotes the missing completely 
at random mechanism; MAR denotes the missing at random mechanism; MNAR denotes the missing not at random mechanism.  
 
4
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Next, the effects of the magnitude of the error in the covariates on the performance of three 
different models were described. As Table 5-8 indicates, Model 1 had slightly larger coverage 
probability (8.12% on average) when the additive variance Var(  )=1 than when the additive 
variance Var(  )=2, regardless of the missingness mechanism. Model 1 had slightly less absolute 
value of relative bias and RMSE when the additive variance Var(  )=1 than when the additive 
variance Var(  )=2. For Model 2, when the additive variance Var(  )=1, the relative bias and 
RMSE were slightly smaller and the coverage probability was slightly greater than when the 
additive variance Var(  )=2 under the MCAR and MAR conditions. Both Model 1 and Model 2 
were not sensitive to the different values of the sensitivity and specificity of the binary covariate. 
And for the Model 3, the results were similar across different magnitudes of the measurement 
error in the covariates.  
 
 
 
 
 
 
 
Table 5-9: Relative bias, RMSE and 95% confidence interval coverage for different conditions of measurement error in covariates 
when the size of the validation dataset is 0.20 , Frequentist MI model with bias correction 
Additive 
Variance 
Misclassification Model 1 
Relative Bias (%) RMSE Coverage 
  MCAR MAR MNAR MCAR MAR MNAR MCAR MAR MNAR 
 
1 
SN=SP=0.90 -1.35 -2.86 -19.02 0.0016 0.0020 0.0096 0.72 0.74 0.03 
SN=SP=0.70 -1.29 -2.85 -19.12 0.0016 0.0020 0.0096 0.73 0.74 0.03 
 
2 
SN=SP=0.90 -2.63 -3.92 -19.68 0.0020 0.0024 0.0099 0.66 0.62 0.02 
SN=SP=0.70 -2.74 -3.96 -19.79 0.0020 0.0024 0.0100 0.65 0.62 0.02 
  Model 2 
  Relative Bias (%) RMSE Coverage 
  MCAR MAR MNAR MCAR MAR MNAR MCAR MAR MNAR 
 
1 
SN=SP=0.90 -22.89 -68.08 -72.06 0.0117 0.0339 0.0358 0.07 0.00 0.00 
SN=SP=0.70 -22.71 -68.13 -72.18 0.0116 0.0339 0.0359 0.08 0.00 0.00 
 
2 
SN=SP=0.90 -25.70 -69.75 -73.42 0.0131 0.0347 0.0365 0.05 0.00 0.00 
SN=SP=0.70 -25.69 -69.80 -73.48 0.0130 0.0347 0.0366 0.04 0.00 0.00 
  Model 3 
  Relative Bias (%) RMSE Coverage 
  MCAR MAR MNAR MCAR MAR MNAR MCAR MAR MNAR 
 
1 
SN=SP=0.90 -0.29 -1.49 -18.99 0.0015 0.0016 0.0095 0.74 0.83 0.02 
SN=SP=0.70 -0.19 -1.44 -19.00 0.0015 0.0016 0.0096 0.75 0.83 0.02 
 
2 
SN=SP=0.90 -0.13 -1.46 -18.92 0.0015 0.0016 0.0095 0.74 0.83 0.02 
SN=SP=0.70 -0.30 -1.46 -18.94 0.0015 0.0016 0.0095 0.74 0.83 0.02 
Note: Model 1 is the predictive model with the observed disease status and the imputed disease predictors as covariates; Model 2 is the 
predictive model with the imputed disease predictors as covariates only; Model 3 is the predictive model with the observed disease 
status as covariate only. Model 3 is the predictive model with the observed response only. SN = sensitivity; SP = specificity. RMSE = 
root mean squared error. MCAR denotes the missing completely at random mechanism; MAR denotes the missing at random 
mechanism; MNAR denotes the missing not at random mechanism.  
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The results shown in Table 5-9 were based on the validation dataset whose size was 0.20 . 
Under the MCAR, MAR and MNAR conditions and when the additive variance Var(  )=1, the 
coverage probability of Model 1 was 10.69%, 19.35% and 50.00% greater than the coverage 
probability when the additive variance Var(  )=2, respectively. For example, under the MAR 
condition when the additive variance Var(  )=1 and sensitivity and specificity were both equal to 
0.90, the relative bias, RMSE and coverage probability were -2.86%, 0.0020 and 0.74, 
respectively. Under the MAR condition, when the additive variance Var(  )=1 and sensitivity 
and specificity were both equal to 0.70, the relative bias, RMSE and coverage probability were   
-2.85%, 0.0020 and 0.74, respectively. However, under the MAR condition when the additive 
variance Var(  )=2 and sensitivity and specificity were equal to 0.90, the relative bias, RMSE 
and coverage probability were -3.92%, 0.0024 and 0.62, respectively. For Model 2, when the 
additive variance Var(  )=2, the average of the absolute relative bias over three the missingness 
mechanisms was 3.62% greater than that when the additive variance Var(  )=1. However, the 
coverage probability of Model 2 was very small and does not change as the magnitude of 
measurement error in the covariates change.  Model 3 still had stable values of relative bias, 
RMSE, and coverage probability with the additive variance increases and sensitivity and 
specificity decrease. For example, under the MAR condition the coverage was 0.83 regardless of 
the amount of error in the continuous covariate and the sensitivity and specificity of the binary 
covariate.              
Table 5-10: Relative bias, RMSE and 95% confidence interval coverage for different conditions of measurement error in covariates 
when the size of the validation dataset is 0.35 , Frequentist MI model with bias correction 
Additive 
Variance 
Misclassification Model 1 
Relative Bias (%) RMSE Coverage 
  MCAR MAR MNAR MCAR MAR MNAR MCAR MAR MNAR 
 
1 
SN=SP=0.90 -1.37 -2.86 -18.36 0.0014 0.0020 0.0092 0.82 0.74 0.01 
SN=SP=0.70 -1.38 -2.85 -18.34 0.0014 0.0020 0.0092 0.82 0.74 0.01 
 
2 
SN=SP=0.90 -2.41 -3.92 -18.84 0.0017 0.0024 0.0094 0.74 0.62 0.01 
SN=SP=0.70 -2.41 -3.96 -18.86 0.0017 0.0024 0.0094 0.74 0.62 0.01 
  Model 2 
  Relative Bias (%) RMSE Coverage 
  MCAR MAR MNAR MCAR MAR MNAR MCAR MAR MNAR 
 
1 
SN=SP=0.90 -37.95 -68.08 -77.96 0.0190 0.0339 0.0388 0.00 0.00 0.00 
SN=SP=0.70 -37.87 -68.13 -78.00 0.0190 0.0339 0.0388 0.00 0.00 0.00 
 
2 
SN=SP=0.90 -40.27 -69.75 -78.93 0.0202 0.0347 0.0393 0.00 0.00 0.00 
SN=SP=0.70 -40.22 -69.80 -79.02 0.0201 0.0347 0.0393 0.00 0.00 0.00 
  Model 3 
  Relative Bias (%) RMSE Coverage 
  MCAR MAR MNAR MCAR MAR MNAR MCAR MAR MNAR 
 
1 
SN=SP=0.90 -0.14 -1.49 -18.08 0.0013 0.0016 0.0091 0.87 0.83 0.01 
SN=SP=0.70 -0.12 -1.44 -18.07 0.0013 0.0016 0.0091 0.87 0.83 0.01 
 
2 
SN=SP=0.90 -0.07 -1.46 -18.09 0.0013 0.0016 0.0091 0.87 0.83 0.01 
SN=SP=0.70 -0.14 -1.46 -18.06 0.0013 0.0016 0.0090 0.87 0.83 0.01 
Note: Model 1 is the predictive model with the observed disease status and the imputed disease predictors as covariates; Model 2 is the 
predictive model with the imputed disease predictors as covariates only; Model 3 is the predictive model with the observed disease 
status as covariate only. SN = sensitivity; SP = specificity. RMSE = root mean squared error. MCAR denotes the missing completely 
at random mechanism; MAR denotes the missing at random mechanism; MNAR denotes the missing not at random mechanism.
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Table 5-10 reveals that when the size of the validation dataset increased to 0.35  the 
magnitude of the measurement error in the covariates remained influential for Model 1 but has 
less impact on the results for Model 2. Specifically, under the MCAR condition, when the 
additive variance Var(  )=1, the coverage was 10.81% larger than when the additive variance 
Var(  )=2. And under the MAR condition when the additive variance Var(  )=1, the coverage 
was 19.35% greater than when the additive variance Var(  )=2. For Model 2, there was little 
difference in the relative bias and RMSE between the two measurement error conditions for the 
continuous covariate, but the coverage for Model 2 were all close to zero. As for Model 3, it still 
remained stable across different magnitude of the measurement error in covariates.
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Figure 5-7 Prevalence estimates of Model 3 by number of imputations when the sensitivity is 
0.60, Frequentist MI model with bias correction, and the missingness mechanism is MCAR 
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The effect of the number of imputations is examined next. Figure 5-7 reveals that the 
average prevalence estimate remains close to 0.05 regardless the size of the validation dataset. In 
panel A, the prevalence estimates range from 0.03 to 0.08 and does not change with the number 
of imputations. Specifically, the minimum and maximum of the prevalence estimates with three 
imputations are 0.030 and 0.076 (mean is 0.049) and the minimum and maximum of the 
prevalence estimates with forty imputations are 0.034 and 0.066 (mean is 0.050). Panel C 
displays the range of prevalence estimates when the size of the validation dataset is 0.35 . The 
range is similar for different number of imputations. For example, the minimum and maximum 
of the prevalence estimates with three imputations are 0.042 and 0.058 (mean is 0.048) and the 
minimum and maximum of the prevalence estimates with forty imputations are 0.040 and 0.056 
(mean is 0.048). Comparing panel A and panel C, we can notice that the range of the prevalence 
estimates based on 0.35  validation dataset is eloquently smaller than that based on 0.05  
validation dataset through all different numbers of imputations. But the mean of the prevalence 
estimates over 500 replications for specific number of imputations remains close to the true 
prevalence.           
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Figure 5-8 Standard errors of prevalence estimates of Model 3 by number of imputations when 
the sensitivity is 0.60, Frequentist MI model with bias correction, and the missingness 
mechanism is MCAR 
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As Figure 5-8 reveals, the range of the standard error of the prevalence estimate decrease 
from almost 0.020 to just over 0.005 when the number of imputations increases from 3 to 15. 
However, when the number of imputations is 20, the range increases, and is similar in size to 
when the number of imputations is three. When the number of imputations is 40, the range of the 
standard error of prevalence estimate decreases to approximately 0.005. The mean of the 
standard error of prevalence estimate decreased by 45.87% as the number of imputations 
increases from three to 10. Panel C of Figure 5-8 shows the box plot of the standard error of 
prevalence estimate when the size of the validation dataset is 0.35 . In this situation, the mean 
of the standard error of prevalence estimate slightly decrease from 0.002 to 0.001 and the range 
also decreases with the number of imputations increases except than when the number of 
imputations is 10.  
For the MCAR condition, the range and mean of the prevalence estimates was constant 
across the different dataset size conditions. As for the range and mean of the standard error of the 
prevalence estimates they decreased significantly as the number of imputations increased when 
the size of the validation dataset was 0.05  and decrease slightly when the size of the validation 
data set was 0.35 . 
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Figure 5-9 Prevalence estimates of Model 3 by number of imputations when the sensitivity is 
0.60, Frequentist MI model with bias correction, and the missingness mechanism is MAR 
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Figure 5-10 Standard errors of prevalence estimates of Model 3 by number of imputations when 
the sensitivity is 0.60, Frequentist MI model with bias correction, and the missingness 
mechanism is MAR
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Figure 5-11 Prevalence estimates of Model 3 by number of imputations when the sensitivity is 
0.60, Frequentist MI model with bias correction, and the missingness mechanism is MNAR
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Figure 5-12 Standard errors of prevalence estimates of Model 3 by number of imputations when 
the sensitivity is 0.60, Frequentist MI model with bias correction, and the missingness 
mechanism is MNAR 
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Other than the figures shown above, the trend of the prevalence estimates and standard 
errors of prevalence estimates with increasing size of the validation dataset and the number of 
imputations for other values of sensitivity and models were same as when the sensitivity was 
0.60 and for Model 3.  
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CHAPTER 6. CONCLUSIONS AND DISCUSSION 
The purpose of the research was to investigate different MI methods that can estimate the 
disease prevalence accurately and examine the factors that influence the performance of MI 
methods. The simulation study fulfilled the objectives that MI methods using Frequentist or 
Bayesian logistic regression model as predictive model could improve the prevalence estimate; 
the characteristics of model-based case-detection algorithms including sensitivity of observed 
disease status and type and magnitude of measurement error in the predictors of disease status 
slightly influenced the performance of the MI methods; and the effect of the size of the 
validation dataset was significant to accurately estimate the prevalence while increasing the 
number of imputations on the performance of MI methods only decreased the standard error of 
the prevalence estimate.  
6.1 Conclusions 
The Frequentist MI model with bias correction had superior performance of estimating 
disease prevalence to Frequentist MI model without bias correction and Bayesian MI model 
regardless the size of the validation dataset, which was demonstrated via the simulation study in 
scenario 1. In scenario 1, the Frequentist MI model with bias correction performed well under 
MCAR and MAR with small relative bias, RMSE and reasonable coverage probability of the 
95% confidence interval. When the sensitivity was 0.75 or 0.90, the Bayesian MI model had 
smaller relative bias and RMSE than the Frequentist MI model without bias correction, but under 
MCAR the Bayesian MI model had substantially smaller coverage compared with the 
Frequentist MI model without bias correction. For the Bayesian MI model, the relative bias 
under MNAR was greater than the relative bias under MCAR and MAR, and the relative bias 
decreased with the size of the vlidation dataset increasing. For the Frequentist MI model without 
bias correction, the relative bias and RMSE increased with the size of the validation increasing.  
In both scenario 1 and scenario 2, the missingness mechanism had a significant impact on 
the accuracy of the prevalence estimates. Especially, when the missingness mechanism was 
MNAR that is the data violated the MAR assumption of the MI methods, even the Frequentist 
MI model with bias correction would have very small coverage.  
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Based on the results of scenario 1 and scenario 2, it is demonstrated that the predictive 
model with observed disease status as covariate can achieve the goal to estimate the disease 
prevalence correctly. In scenario 1, the Frequentist MI model with bias correction having 
observed disease status as covariate of the predictive model had the smallest relative bias 
regardless of the missingness mechanism, the size of the validation dataset and the sensitivity of 
the observed disease status. In scenario 2, the Frequentist MI model with bias correction having 
observed disease status as covariate of the predictive model also had the smallest relative bias 
compared with the other two predictive models. Table 5-5, Table 5-6 and Table 5-7 suggest that 
the Model 1 with the observed disease status and imputed disease predictors as covariates and 
Model 3 with observed disease status only can be applied to estimate the prevalence. And the 
model (Model 2) only with imputed disease predictors as covariates has low coverage probability 
indicating that the method to impute the disease predictors first and then use the imputed disease 
predictors to impute the true disease status did not perform well, especially when the missingness 
mechanism is MAR. From Table 5-8, Table 5-9 and Table 5-10, one can quickly make the 
observation that larger additive variance in the continuous disease predictor can result in bigger 
relative bias, RMSE and smaller coverage than when variance is smaller in the disease predictor 
for Model 1. Generally, the Model 3 did not change with the change of the magnitude of the 
measurement error in disease predictors. The reason is that Model 3 only has the observed 
disease status as the covariate of predictive model. However, if the Frequentist MI model without 
bias correction is used, Model 2 performed better than Model 1 and Model 3.   
The effect of the size of the validation dataset was significant both in scenario 1 and 
scenario 2. Increasing the size of the validation dataset reduced the relative bias and RMSE for 
both Frequentist MI model with bias correction and Bayesian MI model as well as for different 
predictive models under different missingness mechanisms. This is reasonable because the larger 
the size of the validation dataset is the more information are provided to build the model which 
can correctly reflect the association between the observed disease status and true disease status. 
It is recommended to increase the size of the validation dataset when implementing the MI 
methods to correct for measurement errors.  
The consequence of the sensitivity of the observed disease status depends on the MI method 
and the missingness mechanism. Generally, if the missingness mechanism is MNAR, the relative 
bias and RMSE would decrease with the sensitivity of the observed disease status increasing. In 
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scenario 1, it is also shown that the Bayesian MI model had smaller relative bias and RMSE 
when the sensitivity of the observed disease status is increased. 
The results for scenario 1 and scenario 2 also demonstrate that a large number of 
imputations can improve the precision of the prevalence estimate regardless the missingness 
mechanism. The range and mean of standard errors for different validation dataset sizes and 
different missingness mechanisms (including MCAR, MAR and MNAR) all decreased in 
varying degrees with the number of imputations increasing. Overall, we can see that the effect of 
the number of imputations was important when the size of the validation dataset was 0.05 , 
while it became less important when the size of the validation dataset was as large as 0.35 , 
regardless of the missingness mechanism. Increase the validation dataset can improve both the 
accuracy and precision of prevalence estimate, and increase the number of imputations can only 
improve the precision.   
6.2 Discussion 
The predictive models in this research were constructed using a logistic regression model 
with selected variables. In medical research, the logistic regression model is widely used to 
construct predictive models
90,91
. By using logistic regression, the observed disease status is 
directly modeled to the true disease status. In this way, the MI can be easily implemented to 
impute the individual’s true disease status so that the prevalence of the entire population is 
estimated. On the other hand, the predictive model can also be defined by the conditional 
distribution of true disease status on all the information provided by observed disease status and 
disease predictors. The alternative approach is sequential regression multiple imputation, which 
specifies a series of separate conditional distributions for each incomplete variable without the 
need to fit a multivariate model
92
. In this way, the relationship between the observed disease 
status and true disease status is studied based on the separate models, which preserves the 
structure in the data as well as the uncertainty about this structure and includes any knowledge 
about the process that generated the missing data. Usually, these foundational models are 
specified by expertize in the field, which may also be misspecified. We also studied the 
sequential regression multiple imputation that can be used as the predictive models in Frequentist 
approach and as the joint distribution in fully Bayesian approach (Appendix C). The sequential 
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regression models include the model of sensitivity and specificity (i.e., in scenario 1 is the true 
disease status conditional on the observed disease status; in scenario 2 is the true disease status 
conditional on the observed disease status and disease predictors), the disease model, the 
measurement error model for continuous disease predictor, and the misclassification model for 
binary disease predictor.   
In scenario 1, the comparison of the Bayesian MI model and the Frequentist MI model 
without bias correction substantiated the theory that the Bayesian approach with non-informative 
prior distribution should have approximate results as the maximum likelihood estimation of 
Frequentist approach. However, in reality the size of the validation dataset is quite small and the 
prevalence is very low. That means we encountered the problem of small sample size and sparse 
data (i.e., data with few or no subjects at crucial combinations of variable values). For the 
Frequentist MI model without bias correction, the relative bias and RMSE were the largest when 
the sensitivity was 0.90 under the MNAR condition. The reason is the very small sample size and 
the unbalanced values in the contingency table with sensitivity 0.9 and specificity 1.0. We 
implemented the bias correction algorithm with maximum likelihood estimation in Frequentist 
approach and it produced small relative bias, good precision and confidence coverage. The 
Bayesian approach may be improved by selecting an appropriate prior distribution based on 
expert recommendation. A number of studies have developed different informative prior 
distributions that can also improve the inference of Bayesian approach
93,94
. 
In scenario 2, we investigated predictive models with different selected variables as 
covariates of the predictive model based on Frequentist MI model with bias correction. It is 
generally recommended to include a rich set of predictors that are relevant to the imputed 
variable when imputing missing values
95
. However, the results indicate that the observed disease 
status as covariate of the predictive model to impute the true disease status is as good as the 
predictive model with observed disease status and imputed disease predictors. If the primary 
object of this research is to correctly estimate the association between the disease predictors and 
the disease status, using the predictive model with observed disease status and imputed disease 
predictors to impute true disease status should be helpful to correctly estimate the coefficients of 
the disease model.      
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The assumption of the MI methods in this research was that non-differential measurement 
error exists in the covariates, which means the measurement error models are the same for 
individuals with disease as those without disease. In AHDs, the data are usually collected 
prospectively, thus the non-differential measurement error assumption of the covariates is 
assumed to be reasonable. In addition, the non-differential measurement error assumption is 
appropriate, except for case-control studies and when          is not the observed measure 
of           but a surrogate variable as a proxy of  . That means for case-control studies the 
measure of the true values tend to be biased. Thus the methods here may not be applied to 
problems in which measurement error models are different for individuals with and without 
disease.  
If the missingness mechanism is MNAR, MI methods could not substantially improve the 
accuracy of population disease prevalence estimates over the naïve estimation method. So it is 
important to identify the missingness mechanism based on how the validation study was 
conducted. In one study, the diagnoses contained in the medical charts of the cohort of Quebec 
seniors enrolled in the medical office of the 21
st
 century (MOXXI) study were used to validate 
administrative health data
5
. This validation dataset should result in the MCAR mechanism for 
missing records of people not enrolled in the MOXXI study because the study adopted a 
randomized trial design in a study population of 110 primary care physicians in Montreal, 
Quebec. In a different study, Bone Mineral Density (BMD) testing results from Manitoba were 
used to assess the validity of osteoporosis cases ascertained from administrative databases.
11
 It is 
likely that the MAR mechanism characterizes the missing test results. Bone Mineral Density 
(BMD) testing in Manitoba requires physician referral; individuals who are referred are more 
likely to be female and age 65 years or older. Thus, whether a person is in the testing program is 
conditional on observed covariates. Another study to validate the accuracy of identification of 
patients with immune thrombocytopenic purpura (ITP) through administrative records
38
 is likely 
to result in MNAR missing diagnoses from the Electronic Patient Record (the medical record) of 
people who do not have the records. The reason is that the records were retrieved from inpatients 
and outpatients with ITP as a primary or secondary diagnosis which was missing if people do not 
have the medical record of ITP.   
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6.3 Summary and Recommendations  
Our finding suggest that using MI methods to improve the accuracy of case ascertainment in 
AHDs can result in a valid dataset for public usage including surveillance, utilization review of 
services, policy evaluation, and risk adjustment. In this research, the MI methods accounted for 
the measurement error both in disease status and disease predictors, which appears frequently in 
practice. More reliable estimates of variability are provided by accommodation of the uncertainty 
caused by missing data. So it is recommended to apply MI methods to correct the potentially 
inaccurate disease diagnoses in AHDs before using the AHDs to do further research or decision-
making.   
We examined MI methods using both a Bayesian and Frequentist logistic model, which, to 
the best of our knowledge, has not previously been studied. Considering the characteristics of the 
AHD, we developed a valid MI method (in Frequentist approach with Bias Correction algorithm) 
that can estimate the disease prevalence even though the validation dataset is small and the 
specificity is close to one.  
From the results, the Frequentist MI with bias correction is not sensitive to the sensitivity of 
the observed disease status under MCAR and MAR missingness mechanisms. Thus the MI 
methods can be applied to address the misclassification of the observed response when it is 
assumed to be under-reported.  
The investigation of the potential factors that may influence the performance of the 
estimation of the disease prevalence provides a guideline for future research to deal with the 
missing data and measurement error problem. The most appropriate method can be implemented 
depending on the missingness mechanism and the size of the validation dataset. If the sampling 
mechanism of the validation dataset can be expected to result in MCAR or MAR missing data in 
the main dataset, the size of the validation dataset is less than 35% of the population, and there is 
no specified prior distribution for the Bayesian method, then the Frequentist MI model with bias 
correction provides more accurate estimates of prevalence and is recommended based on our 
simulation study. When selecting covariates for the predictive model, regardless of whether the 
misclassification of the observed disease status is dependent on or independent of disease 
predictors that contain measurement error, the Frequentist MI model with bias correction is 
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recommended. And it is recommended that when applying the MI method, the number of 
imputations toned not be greater than 20. Not only will more imputations result in a longer 
computational time, but may also decrease the coverage probability (i.e., precision) of the 
confidence intervals.  
6.4 Future Research 
There are a number of opportunities for future research. The study is based on the 
main/validation dataset design in which the validation dataset contains disease status and disease 
predictors measured without error. However, the validation dataset may also contain 
mismeasured values. Further research might explore this situation. Methods for measurement 
error correction with the assumption that the ‘true’ values gathered from validation dataset are 
also error-prone should be investigated.  
We compared the MI methods based on Frequentist logistic model and Bayesian logistic 
model in scenario 1. We would like to explore the MI method using Bayesian logistic model in 
scenario 2 in next step. The MI method using Bayesian logistic model is using MCMC to draw 
the samples of the parameters of the predictive logistic model, then the multiple values of true 
disease status are imputed using the multiple values of the parameters. The fully Bayesian MI 
method that draw the multiple samples of the disease status from the posterior distribution based 
on the joint distribution also deserves investigation so that it can be applied in AHDs.   
In this research, we propose the method to correctly ascertain the disease cases by taking 
use of the observed disease status and relevant disease markers. For future research, the 
association between the true disease status and the disease predictors might be examined. We 
will examine the performance of MI methods to estimate the coefficient of the covariates in the 
disease model.   
The attention of the study has been restricted to the case where the covariates of the disease 
model are independent. The disease markers maybe correlated with each other. Thus extensions 
to the correlated covariates could also be developed.  
71 
  
 
In practice, the MAR assumption is very difficult to test. And the MNAR is possible, so the 
development of the method that can be implemented to deal with the missing data even the 
missingness mechanism is MNAR would be valuable and innovative.
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APPENDIX A: EXTRA RESULTS FOR SCENARIO 1 
 
 
 
Figure A-1 Prevalence estimates for the Frequentist MI model with bias correction when the 
missingness mechanism is MCAR and sensitivity is 0.75  
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Figure A-2 Standard error of prevalence estimate for the Frequentist MI model with bias 
correction when the missingness mechanism is MCAR and sensitivity is 0.75 
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Figure A-3 Prevalence estimates for the Frequentist MI model with bias correction when the 
missingness mechanism is MCAR and sensitivity is 0.90 
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Figure A-4 Standard error of prevalence estimate for the Frequentist MI model with bias 
correction when the missingness mechanism is MCAR and sensitivity is 0.90   
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APPENDIX B 
Table B-1: Relative bias, RMSE and 95% confidence interval coverage when the size of the 
validation dataset is 0.05 , Frequentist MI model without bias correction 
Sensitivity of 
observed 
disease status 
Missing 
mechanism 
Model 1 Model 2 Model 3 
  Relative Bias (%) 
0.60 MCAR -20.29 -3.70 -26.69 
 MAR -22.83 -40.14 -27.66 
 MNAR 119.68 -37.06 -23.45 
0.75 MCAR 11.56 -3.59 -32.07 
 MAR 7.23 -48.14 -33.78 
 MNAR 269.57 -39.44 55.86 
0.90 MCAR 326.42 -3.57 25.50 
 MAR 321.73 -39.72 20.64 
 MNAR 566.74 -37.88 320.38 
  RMSE 
0.60 MCAR 0.0169 0.0048 0.0147 
 MAR 0.0167 0.0206 0.0157 
 MNAR 0.0790 0.0291 0.0329 
0.75 MCAR 0.0276 0.0053 0.0186 
 MAR 0.0256 0.0247 0.0193 
 MNAR 0.1518 0.0286 0.0640 
0.90 MCAR 0.1797 0.0050 0.0467 
 MAR 0.1778 0.0271 0.0445 
 MNAR 0.2967 0.0285 0.1937 
  Coverage 
0.60 MCAR 0.28 0.49 0.33 
 MAR 0.28 0.07 0.32 
 MNAR 0.13 0.02 0.06 
0.75 MCAR 0.27 0.49 0.28 
 MAR 0.26 0.03 0.27 
 MNAR 0.18 0.02 0.12 
0.90 MCAR 0.25 0.49 0.25 
 MAR 0.24 0.02 0.24 
 MNAR 0.18 0.02 0.21 
Note: Model 1 is the predictive model with the observed disease status and the imputed disease 
predictors as covariates; Model 2 is the predictive model with the imputed disease predictors as 
covariates only; Model 3 is the predictive model with the observed disease status as covariate 
only. RMSE = root mean squared error. MCAR denotes the missing completely at random 
mechanism; MAR denotes the missing at random mechanism; MNAR denotes the missing not at 
random mechanism.  
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Table B-2: Relative bias, RMSE and 95% confidence interval coverage when the size of the 
validation dataset is 0.20 , Frequentist MI model without bias correction 
Sensitivity of 
observed 
disease status 
Missing 
mechanism 
Model 1 Model 2 Model 3 
  Relative Bias (%) 
0.60 MCAR -27.06 -5.28 -23.52 
 MAR -31.22 -42.82 -27.51 
 MNAR -53.52 -66.91 -53.85 
0.75 MCAR -31.93 -5.30 -29.37 
 MAR -36.98 -51.81 -34.22 
 MNAR -37.64 -67.00 -50.78 
0.90 MCAR 62.96 -5.27 -35.22 
 MAR 50.10 -60.76 -41.24 
 MNAR 202.53 -66.94 -27.71 
  RMSE 
0.60 MCAR 0.0144 0.0038 0.0127 
 MAR 0.0166 0.0214 0.0148 
 MNAR 0.0276 0.0333 0.0274 
0.75 MCAR 0.0170 0.0038 0.0158 
 MAR 0.0197 0.0256 0.0184 
 MNAR 0.0238 0.0333 0.0263 
0.90 MCAR 0.0481 0.0038 0.0189 
 MAR 0.0434 0.0303 0.0221 
 MNAR 0.1167 0.0333 0.0285 
  Coverage 
0.60 MCAR 0.21 0.63 0.27 
 MAR 0.19 0.00 0.26 
 MNAR 0.03 0.00 0.04 
0.75 MCAR 0.20 0.63 0.24 
 MAR 0.19 0.00 0.23 
 MNAR 0.08 0.00 0.08 
0.90 MCAR 0.22 0.63 0.23 
 MAR 0.22 0.00 0.22 
 MNAR 0.22 0.00 0.14 
Note: Model 1 is the predictive model with the observed disease status and the imputed disease 
predictors as covariates; Model 2 is the predictive model with the imputed disease predictors as 
covariates only; Model 3 is the predictive model with the observed disease status as covariate 
only. RMSE = root mean squared error. MCAR denotes the missing completely at random 
mechanism; MAR denotes the missing at random mechanism; MNAR denotes the missing not at 
random mechanism.  
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Table B-3: Relative bias, RMSE and 95% confidence interval coverage when the size of the 
validation dataset is 0.35 , Frequentist MI model without bias correction 
Sensitivity of 
observed disease 
status 
Missing 
mechanism 
Model 1 Model 2 Model 3 
  Relative Bias (%) 
0.60 MCAR -22.21 -4.62 -19.15 
 MAR -29.32 -42.30 -26.30 
 MNAR -53.42 -66.94 -52.62 
0.75 MCAR -26.13 -4.53 -23.94 
 MAR -34.83 -51.63 -32.99 
 MNAR -49.10 -66.96 -49.24 
0.90 MCAR -0.31 -4.60 -28.94 
 MAR -13.44 -60.51 -39.24 
 MNAR 88.17 -66.89 -44.80 
  RMSE 
0.60 MCAR 0.0118 0.0033 0.0104 
 MAR 0.0156 0.0211 0.0141 
 MNAR 0.0271 0.0333 0.0267 
0.75 MCAR 0.0139 0.0033 0.0129 
 MAR 0.0185 0.0257 0.0176 
 MNAR 0.0254 0.0333 0.0253 
0.90 MCAR 0.0178 0.0033 0.0155 
 MAR 0.0191 0.0301 0.0210 
 MNAR 0.0586 0.0333 0.0241 
  Coverage 
0.60 MCAR 0.19 0.73 0.27 
 MAR 0.19 0.00 0.24 
 MNAR 0.03 0.00 0.03 
0.75 MCAR 0.20 0.74 0.23 
 MAR 0.20 0.00 0.22 
 MNAR 0.06 0.00 0.07 
0.90 MCAR 0.22 0.74 0.22 
 MAR 0.22 0.00 0.22 
 MNAR 0.19 0.00 0.13 
Note: Model 1 is the predictive model with the observed disease status and the imputed disease 
predictors as covariates; Model 2 is the predictive model with the imputed disease predictors as 
covariates only; Model 3 is the predictive model with the observed disease status as covariate 
only. RMSE = root mean squared error. MCAR denotes the missing completely at random 
mechanism; MAR denotes the missing at random mechanism; MNAR denotes the missing not at 
random mechanism.  
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APPENDIX C 
Based on the conditional distribution, the predictive model for imputing the missing true 
response in the main dataset is conditional on the information of observed response, true 
covariates and observed covariates. 
                   
             
            
                     (C-1)     
To factor the joint distribution                    is dependent on the assumptions of 
the variables. The true disease predictors    and    are independent. From section 3.2, the forms 
of the measurement error models are clarified. When the misclassification of the observed 
response is independent on the disease predictors which is in Scenario 1 of our study, the 
decomposition of the joint distribution of                    is 
                                                                             (C-2)       
The relationship between the observed disease status   and the true disease status   is 
described by measures of sensitivity and specificity. The probability of   conditional on    and 
   is the disease model in Equation 1, which reflects the relationship between the disease and 
predictors. When the misclassification of the observed disease status is dependent on the disease 
predictors, the decomposition of the joint distribution of                    is 
                                                                    (C-3)   
The relationship between the observed disease status   and the true disease status   is 
dependent on the true disease predictors, which means the sensitivity and specificity of the 
observed disease status   varies across different values of the disease predictors. It characterizes 
how the errors appear in the observed response. Also, the probability of   conditional on    and 
   is the disease model as Equation 1 that reflects the relationship between the disease and 
disease markers.   
We develop the sequential regression MI method first for the scenario 1 when the 
misclassification of the observed disease status is independent of the disease predictors. Based on 
the decomposition of the joint distribution of                    as Equation 23, we can 
have 
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As for the sequential regression MI method for the scenario 2 when the misclassification of 
the observed disease status is dependent on the disease predictors, based on the decomposition of 
the joint distribution of                    as Equation 24 we can have 
                     
 
                                                       
∑                                        
 
Based on this predictive model for true disease status, the probability of disease conditional 
on the disease predictors need to be estimated from validation dataset, the sensitivity and 
specificity of the observed disease status also need to be estimated from the validation dataset. 
Since in the main dataset the true values of the covariates are unobservable, this predictive model 
also needs more information to be applied to correct for measurement error. 
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APPENDIX D 
Computer Simulation Program for Scenario 1: Misclassification of Observed Disease 
Status is Independent of Disease Predictors 
Following program code were run for the conditions that when the sensitivity of the 
observed disease status was 0.60, the size of the validation dataset was 0.05N, the number of 
imputations including 3, 5, 10, 15, 20 and 40, and the missingness mechanism was specified as 
MCAR, MAR or MNAR.   
Libname MCAR 'C:\MISIM Program\MCAR'; 
proc iml; 
** Specify simulation parameters**; 
ntot=10000; **total number of observations in the dataset**; 
specificity=1.0; **Specificity of whole population dataset**; 
nsim=500; **number of simulations**; 
sensitivity=0.6; 
valrate=0.05; 
numberofimpute={3 5 10 15 20 40}; 
beta0=-2.785; **Specify the coefficient value**; 
beta1=0.539;  
beta2=-0.693; 
**create counters for disease state**; 
indtrue=j(ntot,1,.); **Temporary indicator of true disease status**; 
indobs=j(ntot,1,.); **Temporary indicator of observed disease status**; 
indval=j(ntot,1,.); **Temporary indicator of presence on the validation cohort**; 
ind=j(ntot,1,.); 
alldata=j(ntot,3,.); 
**ALLDATA: 
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first column = member of the validation cohort (presence=1, otherwise=0), 
second column = true disease state (presence=1, otherwise=0), 
third column = observed disease status (presence=1, otherwise=0); 
 
start binest(beta,cov,y,x,b); **Newton-Raphson Algorithm**; 
 a=nrow(x); 
 b=repeat(0,ncol(x),1); 
 p=j(nrow(x),1,.); 
 oldb=b+1;  
 do iter=1 to 20 while(max(abs(b-oldb))>1e-8); 
  oldb=b; 
  z=x*b; 
  do j=1 to a; 
   if z[j]>0 then pj=1/(1+exp(-z[j])); 
   else pj=exp(z[j])/(1+exp(z[j])); 
   p[j]=pj; 
  end; 
  g=x`*(y-p); 
  w=diag(p*(1-p)`); 
  f=x`*w*x; 
  b=b+ginv(f)*g; 
 end; 
 beta=b; 
 cov=ginv(f); 
finish; 
 
**Bias correction by Cordeiro and McCullagh**; 
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start biascor(bc_beta,bc_cov,y,x,b); 
 a=nrow(x); 
 b=repeat(0,ncol(x),1); 
 p=j(nrow(x),1,.); 
 oldb=b+1; 
 do iter=1 to 20 while(max(abs(b-oldb))>1e-8); 
  oldb=b; 
  z=x*b; 
  do j=1 to a; 
   if z[j]>0 then pj=1/(1+exp(-z[j])); 
   else pj=exp(z[j])/(1+exp(z[j])); 
   p[j]=pj; 
  end; 
  w=diag(p*(1-p)`); 
  f=x`*w*x; 
  d=ginv(f); 
  g=x`*(y-p); 
  e=diag(x*d*x`)*(p-0.5); 
  c=d*x`*w*e; 
  b=b+d*g-c; 
 end; 
 bc_beta=b; 
 bc_cov=d; 
finish; 
 
**Build model to generate vector of regression coefficients for multiple imputations**; 
start betagen(tx,beta,cov,nimpute,seed); 
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 v=nrow(cov); 
 do i=1 to v; **Make sure the covariance matrix is symmetric**; 
  do j=1 to v; 
   if cov[j,i]^=cov[i,j] then cov[j,i]=cov[i,j]; 
  end; 
 end; 
 l=t(root(cov)); 
 z=normal(j(v,nimpute,seed)); 
 x=l*z; 
 x=repeat(beta,1,nimpute)+x; 
 tx=t(x); 
finish; 
 
**Specify starting seeds for all random number generators**; 
randseed=j(11,1,.); 
do i=1 to 11; 
 randseed[i]=int(10000*ranuni(0)); **the seed 0 make sure the ranuni generate differently 
random number each time**; 
end; 
seed1=randseed[1]; 
seed2=randseed[2]; 
seed3=randseed[3]; 
seed4=randseed[4]; 
seed5=randseed[5]; 
seed6=randseed[6]; 
seed7=randseed[7]; 
seed8=randseed[8]; 
seed9=randseed[9]; 
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seed10=randseed[10]; 
seed11=randseed[11]; 
 
ResultAll=j(6,29,.); 
 
do ni=1 to 6; 
 nimpute=numberofimpute[ni]; 
yimpute=j(ntot,nimpute,.); **YIMPUTE: values of disease status for imputation based on 
logistic regression**; 
yimpute_bc=j(ntot,nimpute,.); **YIMPUTE_BC: values of disease status for imputation based 
on bias correction logistic**; 
b_yimpute=j(ntot,nimpute,.);**BYIMPUTE: values of disease status for imputaton based on 
bayesian method**;  
prev=0; **true value of prevalence**; 
obs_prev=0; **value of observed prevalence**; 
obs_bias=0; **The bias of the observed prevalence**; 
SN_U=0; **The sensitivity of the observed response (diagnosis U)**; 
SP_U=0; 
mim_prev=0; **value of prevalence based on bias correction logistic with multiple 
imputation**; 
bias=0; 
rel_bias=0; 
st_bias=0; 
tvar=0;**Total variability of bias correction MIM based on observed response**; 
coverage=0; 
bcmim_prev=0; **value of prevalence based on bias correction logistic with multiple 
imputation**; 
bc_bias=0; 
bcrel_bias=0; 
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bcst_bias=0; 
bc_tvar=0;**Total variability of bias correction MIM based on observed response**; 
bc_coverage=0; 
B_prev=0; **value of prevalence based in Bayesian approach**; 
B_bias=0; **value of bias in Bayesian approach**; 
B_relbias=0; 
B_stbias=0; 
B_tvar=0; 
B_coverage=0; 
 
**Main Body of Simulation**; 
do r=1 to nsim; 
**Generate a continuous covariate data and a binary covariate data**; 
x1=j(ntot,1,.); 
call randseed(seed1); 
call randgen (x1,'normal',0,1); 
x2=j(ntot,1,.); 
call randseed(seed2); 
call randgen (x2,'Bernoulli',.50); 
 
**Create true disease status**; 
do i=1 to ntot; 
 pi=exp(beta0+beta1*x1[i]+beta2*x2[i])/(1+exp(beta0+beta1*x1[i]+beta2*x2[i])); 
 call randseed(seed3); 
 call randgen(yi,'bernoulli',pi); 
 alldata[i,2]=yi; 
end; 
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prev1=sum(alldata[,2])/ntot; 
ytrue=alldata[,2]; 
prev=prev+prev1; 
 
**Create observed disease status**; 
call randseed(seed4);  
call randgen(indobs,'bernoulli',sensitivity); **Depend on Sensitivity only**; 
do i=1 to ntot; 
 if alldata[i,2]=1 then alldata[i,3]=indobs[i]; 
 else alldata[i,3]=0; 
end; 
 
obsprev1=sum(alldata[,3])/ntot; 
obs_prev=obs_prev+obsprev1; 
obs_bias1=prev1-obsprev1; 
obs_bias=obs_bias+obs_bias1; 
**Estimate the sensitivity and specificity of the diagnosis(U)**; 
SN_count=0; 
SP_count=0; 
do i=1 to ntot; 
 if alldata[i,2]=1 & alldata[i,3]=1 then SN_count=SN_count+1; 
 else if alldata[i,2]=0 & alldata[i,3]=0 then SP_count=SP_count+1; 
end; 
SN_U=SN_U+SN_count/sum(alldata[,2]); 
SP_U=SP_U+SP_count/(ntot-sum(alldata[,2])); 
 
**Create indicator for membership in the validation cohort and output validation cohort data into 
a new dataset for analysis**; 
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**MCAR**; 
call randseed(seed5); 
call randgen(indval,'uniform'); 
validss=valrate*ntot; 
temp=rank(indval); 
yset=j(validss,5,1); 
count=0; 
do i=1 to ntot; 
 if temp[i]>validss then alldata[i,1]=0; 
 else if temp[i]<=validss then do; 
  alldata[i,1]=1; 
  count=count+1; 
  yset[count,1]=alldata[i,2]; 
  yset[count,2]=1; 
  yset[count,3]=alldata[i,3]; 
  yset[count,4]=x1[i]; 
  yset[count,5]=x2[i]; 
 end; 
end; 
Varname={y n u x1 x2}; 
create validation from yset [colname=varname]; 
append from yset; 
close validation; 
Val= "Work.Validation"; 
 
**Original estimates of logistic with observed response**; 
call binest(beta,cov,yset[,1],yset[,2:3],b); 
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call betagen(betamat,beta,cov,nimpute,seed6); 
storval=j(nimpute,1,.); 
storvar=j(nimpute,1,.); 
 
do k=1 to nimpute; 
 prob=j(ntot,1,.); 
 fill_vec=j(ntot,1,.);  
 indvar=j(ntot,1,.); 
 do i=1 to ntot; 
  if betamat[k,1]+betamat[k,2]*alldata[i,3]>0 then p=1/(1+exp(-
(betamat[k,1]+betamat[k,2]*alldata[i,3]))); 
  else 
p=exp(betamat[k,1]+betamat[k,2]*alldata[i,3])/(1+exp(betamat[k,1]+betamat[k,2]*alldata[i,3])); 
  prob[i]=p; 
  if alldata[i,1]=0 then do; 
   call randseed(seed7); 
   call randgen(fill,'bernoulli',prob[i]); 
   fill_vec[i]=fill; 
  end; 
  else if alldata[i,1]=1 then fill_vec[i]=alldata[i,2]; 
 end; 
 yimpute[,k]=fill_vec; 
 fprev=sum(fill_vec)/ntot; 
 do i=1 to ntot; 
  indvar[i]=prob[i]*(1-prob[i]); 
 end; 
 predvar=sum(indvar)/ntot**2; 
 storval[k]=fprev; 
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 storvar[k]=predvar; 
end; 
fprev0=sum(storval)/nimpute; 
mim_prev=mim_prev+fprev0; 
bias1=fprev0-prev1; 
bias=bias+bias1; 
rel_bias1=bias1/prev1; **The bias relative to the true prevelance**; 
rel_bias=rel_bias+rel_bias1; 
wvar=sum(storvar)/nimpute;  **Within Imputation Variance of Bias Correction MIM based on 
observed response only**; 
 
do q=1 to nimpute; 
 bvar=sum((storval[q]-sum(storval)/nimpute)**2)/(nimpute-1); 
end; 
 
tvar0=(wvar+(1+1/nimpute)*bvar); **Total variability of Bias Correction MIM based on 
observed response only**; 
tvar=tvar+tvar0; 
SE=sqrt(tvar0); 
st_bias1=bias1/SE; 
st_bias=st_bias+st_bias1; 
LCI=prev-1.96*SE; 
UCI=prev+1.96*SE; 
a=LCI<=prev1 & prev1<=UCI; 
coverage=coverage+a; 
 
**Bias Correction estimates of logistic with observed response**; 
call biascor(bc_beta,bc_cov,yset[,1],yset[,2:3],b); 
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call betagen(bcbetamat,bc_beta,bc_cov,nimpute,seed8); 
bc_storval=j(nimpute,1,.); 
bc_storvar=j(nimpute,1,.); 
 
do k=1 to nimpute; 
 bc_prob=j(ntot,1,.); 
 bcfill_vec=j(ntot,1,.);  
 bc_indvar=j(ntot,1,.); 
 do i=1 to ntot; 
  if bcbetamat[k,1]+bcbetamat[k,2]*alldata[i,3]>0 then bcp=1/(1+exp(-
(bcbetamat[k,1]+bcbetamat[k,2]*alldata[i,3]))); 
  else 
bcp=exp(bcbetamat[k,1]+bcbetamat[k,2]*alldata[i,3])/(1+exp(bcbetamat[k,1]+bcbetamat[k,2]*al
ldata[i,3])); 
  bc_prob[i]=bcp; 
  if alldata[i,1]=0 then do; 
   call randseed(seed9); 
   call randgen(bcfill,'bernoulli',bc_prob[i]); 
   bcfill_vec[i]=bcfill; 
  end; 
  else if alldata[i,1]=1 then bcfill_vec[i]=alldata[i,2]; 
 end; 
 yimpute_bc[,k]=bcfill_vec; 
 bcprev=sum(bcfill_vec)/ntot; 
 do i=1 to ntot; 
  bc_indvar[i]=bc_prob[i]*(1-bc_prob[i]); 
 end; 
 bcpredvar=sum(bc_indvar)/ntot**2; 
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 bc_storval[k]=bcprev; 
 bc_storvar[k]=bcpredvar; 
end; 
 
bc_prev=sum(bc_storval)/nimpute; 
bcmim_prev=bcmim_prev+bc_prev; 
bc_bias1=bc_prev-prev1; 
bc_bias=bc_bias+bc_bias1; 
bcrel_bias1=bc_bias1/prev1; **The bias relative to the true prevelance**; 
bcrel_bias=bcrel_bias+bcrel_bias1; 
bc_wvar=sum(bc_storvar)/nimpute;  **Within Imputation Variance of Bias Correction MIM 
based on observed response only**; 
 
do q=1 to nimpute; 
 bc_bvar=sum((bc_storval[q]-sum(bc_storval)/nimpute)**2)/(nimpute-1); 
end; 
 
bc_tvar0=(bc_wvar+(1+1/nimpute)*bc_bvar); **Total variability of Bias Correction MIM based 
on observed response only**; 
bc_tvar=bc_tvar+bc_tvar0; 
bc_SE=sqrt(bc_tvar0); 
bcst_bias1=bc_bias1/bc_SE; 
bcst_bias=bcst_bias+bcst_bias1; 
bc_LCI=bc_prev-1.96*bc_SE; 
bc_UCI=bc_prev+1.96*bc_SE; 
bca=bc_LCI<=prev1 & prev1<=bc_UCI;   
bc_coverage=bc_coverage+bca; 
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submit Val; 
proc mcmc data=&Val ntu=1000 nmc=21000 nthin=100 nbi=1000 outpost=valest seed=2481; 
 ods select PostSummaries PostIntervals mcse ess ; 
 parms (alpha0 alpha1) 0; 
 prior alpha0 alpha1 ~ normal(0, var=1000); 
 p = logistic(alpha0+alpha1*u); 
 model Y ~ binomial(n,p); 
run; 
endsubmit; 
 
declare DataObject dobj; 
dobj=DataObject.CreateFromServerDataSet("Work.valest"); 
postn=dobj.GetNumObs(); 
dobj.GetVarData("alpha0",alpha0); 
dobj.GetVarData("alpha1",alpha1); 
 
postsample=alpha0||alpha1; 
randind=j(nimpute,1,.); 
call randseed(seed10); 
call randgen(randind,'uniform'); 
MIsample=j(nimpute,2,.); 
B_Yimpute=j(ntot,nimpute,.); 
B_storval=j(nimpute,1,.); 
B_storvar=j(nimpute,1,.); 
 
do j=1 to nimpute; 
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 B_prob=j(ntot,1,.); 
 B_fill_vec=j(ntot,1,.); 
 B_indvar=j(ntot,1,.); 
 MIind=int(randind[j,]*postn)+1; 
 MIsample[j,]=postsample[MIind,]; 
 do i=1 to ntot; 
  if MIsample[j,1]+MIsample[j,2]*alldata[i,3]>0 then bp=1/(1+exp(-
(MIsample[j,1]+MIsample[j,2]*alldata[i,3]))); 
  else bp=exp(MIsample[j,1]+MIsample[j,2]*alldata[i,3])/(1+exp(-
(MIsample[j,1]+MIsample[j,2]*alldata[i,3]))); 
  B_prob[i]=bp; 
  if alldata[i,1]=0 then do; 
   call randseed(seed11); 
   call randgen(B_fill,'bernoulli',B_prob[i]); 
   B_fill_vec[i]=B_fill; 
  end; 
  else if alldata[i,1]=1 then B_fill_vec[i]=alldata[i,2]; 
 end; 
 B_Yimpute[,j]=B_fill_vec; 
 Bprev=sum(B_Yimpute[,j])/ntot; 
 do i=1 to ntot; 
  B_indvar[i]=B_prob[i]*(1-B_prob[i]); 
 end; 
 Bpredvar=sum(B_indvar)/ntot**2; 
 B_storval[j]=Bprev; 
 B_storvar[j]=Bpredvar; 
end; 
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B_prev0=sum(B_storval)/nimpute; 
B_prev=B_prev+B_prev0; 
B_bias0=B_prev0-prev1; 
B_bias=B_bias+B_bias0; 
B_relbias0=B_bias0/prev1; **The bias relative to the true prevelance**; 
B_relbias=B_relbias+B_relbias0; 
B_wvar=sum(B_storvar)/nimpute;  **Within Imputation Variance of Bias Correction MIM 
based on observed response only**; 
 
do q=1 to nimpute; 
 B_bvar=sum((B_storval[q]-sum(B_storval)/nimpute)**2)/(nimpute-1); 
end; 
 
B_tvar0=(B_wvar+(1+1/nimpute)*B_bvar); **Total variability of Bias Correction MIM based 
on observed response only**; 
B_tvar=B_tvar+B_tvar0; 
B_SE=sqrt(B_tvar0); 
B_stbias0=B_bias0/B_SE; 
B_stbias=B_stbias+B_stbias0; 
B_LCI=B_prev0-1.96*B_SE; 
B_UCI=B_prev0+1.96*B_SE; 
Ba=B_LCI<=prev1 & prev1<=B_UCI;  
B_coverage=B_coverage+Ba; 
end; 
 
prev=prev/nsim; 
obs_prev=obs_prev/nsim; 
obs_bias=obs_bias/nsim; 
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SN_U=SN_U/nsim; 
SP_U=SP_U/nsim; 
mim_prev=mim_prev/nsim; 
bias=bias/nsim; 
rel_bias=rel_bias/nsim; 
st_bias=st_bias/nsim; 
tvar=tvar/nsim; 
mse=tvar+bias**2; 
rmse=sqrt(mse); 
coverage=coverage/nsim; 
bcmim_prev=bcmim_prev/nsim; 
bc_bias=bc_bias/nsim; 
bcrel_bias=bcrel_bias/nsim; 
bcst_bias=bcst_bias/nsim; 
bc_tvar=bc_tvar/nsim; 
bc_mse=bc_tvar+bc_bias**2; 
bc_rmse=sqrt(bc_mse); 
bc_coverage=bc_coverage/nsim; 
B_prev=B_prev/nsim; 
B_bias=B_bias/nsim; 
B_relbias=B_relbias/nsim; 
B_stbias=B_stbias/nsim; 
B_tvar=B_tvar/nsim; 
B_mse=B_tvar+B_bias**2; 
B_rmse=sqrt(B_mse); 
B_coverage=B_coverage/nsim; 
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SEED=seed1||seed2||seed3||seed4||seed5||seed6||seed7||seed8||seed9||seed10||seed11; 
Parameter=ntot||sensitivity||valrate||nimpute; 
OBS=nsim||prev||obs_prev||obs_bias; 
MIM=mim_prev||bias||rel_bias||st_bias||tvar||rmse||coverage; 
BCMIM=bcmim_prev||bc_bias||bcrel_bias||bcst_bias||bc_tvar||bc_rmse||bc_coverage; 
B_MIM=B_prev||B_bias||B_relbias||B_stbias||B_tvar||B_rmse||B_coverage; 
Result=Parameter||OBS||MIM||BCMIM||B_MIM; 
ResultAll[1#(nimpute=3)+2#(nimpute=5)+3#(nimpute=10)+4#(nimpute=15)+5#(nimpute=20)+
6#(nimpute=40),]=Result; 
 
Varnames={TotalNumber Sensitivity ValRate NImpute SimulationNumber Prevalence 
ObservedPrevalence ObserPrevBias FIPrev FIBias FIRelBias FIStBias FIVar FIRMSE 
FICoverage BCPrev BCBias BCRelBias BCStBias BCVar BCRMSE BCCoverage BIPrev 
BIBias BIRelBias BIStBias BIVar BIRMSE BICoverage}; 
end; 
Create MCAR.MCAR05S65 from ResultAll [colname=varnames]; 
append from ResultAll; 
close MCAR.MCAR05S65; 
Create MCAR.SEED05S65 from SEED; 
append from SEED; 
close MCAR.SEED05S65; 
quit; 
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Computer Simulation Program for Scenario 2: Misclassification of Observed Disease 
Status is Dependent on Disease Predictors 
Following program code were run for the conditions that when the sensitivity of the 
observed disease status was specified as 0.60, 0.75 or 0.90, the size of the validation dataset was 
0.05N, the number of imputations including 3, 5, 10, 15, 20 and 40, the sensitivity and specificity 
of the binary disease predictor were 0.90 or 0.70, and the additive variance of the continuous 
disease predictor was 1 or 2, and the missingness mechanism was specified as MCAR, MAR or 
MNAR. 
LIBNAME MCAR2 'C:\MISIM Program\MCAR2'; 
proc iml; 
**Multiple Imputation in the Frequentist Approach**; 
**This program is to compare Naive Logistic Regression and Bias Corrected Logistic 
Regression for observed response is depend on covariates**; 
 
** Specify simulation parameters**; 
ntot=10000; **total number of observations in the dataset**; 
nsim=500; **number of simulations**; 
sensitivity=0.6; 
valrate=0.05; 
numberofimpute={3 5 10 15 20 40}; 
beta0=-2.785; **Specify the coefficient value**; 
beta1=0.539;  
beta2=-0.693; 
**The coefficient for sensitivity 0.60 of the observed disease status**; 
rho0=1.2; 
rho1=-0.26934; 
rho2=-1.7536; 
**The coefficient for sensitivity 0.75 of the observed disease status**; 
rho0=1.8295; 
rho1=-0.269; 
rho2=-1.386; 
**The coefficient for sensitivity 0.90 of the observed disease status**; 
rho0=1.995; 
rho1=-0.26934; 
rho2=1.36; 
**create counters for disease state**; 
indval=j(ntot,1,.); **Temporary indicator of presence on the validation cohort**; 
alldata=j(ntot,3,.); 
indobs1=j(ntot,1,.); ** Temporary indicator of measurment of x1**; 
indobs2=j(ntot,1,.); 
**ALLDATA: 
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first column = member of the validation cohort (presence=1, otherwise=0), 
second column = true disease state (presence=1, otherwise=0), 
third column = observed disease status (presence=1, otherwise=0); 
 
**Build Logistic Regression model for estimating the parameters**; 
start binest(beta,cov,y,x,b); **Newton-Raphson Algorithm**; 
 a=nrow(x); 
 b=repeat(0,ncol(x),1); 
 p=j(nrow(x),1,.); 
 oldb=b+1;  
 do iter=1 to 20 while(max(abs(b-oldb))>1e-8); 
  oldb=b; 
  z=x*b; 
  do j=1 to a; 
   if z[j]>0 then pj=1/(1+exp(-z[j])); 
   else pj=exp(z[j])/(1+exp(z[j])); 
   p[j]=pj; 
  end; 
  g=x`*(y-p); 
  w=diag(p*(1-p)`); 
  f=x`*w*x; 
  b=b+ginv(f)*g; 
 end; 
 beta=b; 
 cov=ginv(f); 
finish; 
  
**Bias correction by Cordeiro and McCullagh**; 
start biascor(bc_beta,bc_cov,y,x,b); 
 a=nrow(x); 
 b=repeat(0,ncol(x),1); 
 p=j(nrow(x),1,.); 
 oldb=b+1; 
 do iter=1 to 20 while(max(abs(b-oldb))>1e-8); 
  oldb=b; 
  z=x*b; 
  do j=1 to a; 
   if z[j]>0 then pj=1/(1+exp(-z[j])); 
   else pj=exp(z[j])/(1+exp(z[j])); 
   p[j]=pj; 
  end; 
  w=diag(p*(1-p)`); 
  f=x`*w*x; 
  d=ginv(f); 
  g=x`*(y-p); 
  e=diag(x*d*x`)*(p-0.5); 
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  c=d*x`*w*e; 
  b=b+d*g-c; 
 end; 
 bc_beta=b; 
 bc_cov=d; 
finish; 
 
**Linear regression analysis to estimate the parameters of the linear model to impute the true 
continuous covariate**; 
start regress(y,x,b,covb); 
 xpxi=ginv(t(x)*x); 
 beta=xpxi*(t(x)*y); 
 yhat=x*beta; 
 resid=y-yhat; 
 sse=ssq(resid); 
 dfe=nrow(x)-ncol(x); 
 mse=sse/dfe; 
 covbeta=xpxi*mse; 
 b=beta; 
 covb=covbeta; 
finish; 
 
**Build model to generate vector of regression coefficients for multiple imputations**; 
start betagen(tx,beta,cov,nimpute,seed); 
 v=nrow(cov); 
 do i=1 to v; **Make sure the covariance matrix is symmetric**; 
  do j=1 to v; 
   if cov[j,i]^=cov[i,j] then cov[i,j]=cov[j,i]; 
  end; 
 end; 
 l=t(root(cov)); 
 z=normal(j(v,nimpute,seed)); 
 x=l*z; 
 x=repeat(beta,1,nimpute)+x; 
 tx=t(x); 
finish; 
 
**Specify starting seeds for all random number generators**; 
randseed=j(27,1,.); 
do i=1 to 27; 
 randseed[i]=int(10000*ranuni(0)); **the seed 0 make sure the ranuni generate differently 
random number each time**; 
end; 
seed1=randseed[1]; 
seed2=randseed[2]; 
seed3=randseed[3]; 
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seed4=randseed[4]; 
seed5=randseed[5]; 
seed6=randseed[6]; 
seed7=randseed[7]; 
seed8=randseed[8]; 
seed9=randseed[9]; 
seed10=randseed[10]; 
seed11=randseed[11]; 
seed12=randseed[12]; 
seed13=randseed[13]; 
seed14=randseed[14]; 
seed15=randseed[15]; 
seed16=randseed[16]; 
seed17=randseed[17]; 
seed18=randseed[18]; 
seed19=randseed[19]; 
seed20=randseed[20]; 
seed21=randseed[21]; 
seed22=randseed[22]; 
seed23=randseed[23]; 
seed24=randseed[24]; 
seed25=randseed[25]; 
seed26=randseed[26]; 
seed27=randseed[27]; 
 
ResultAll=j(24,69,.); 
**Vary the parameters**; 
do MEvar=1 to 2; **The varianace of additional measurement error of the continuous covariate 
x1**; 
 
 do XSN=1 to 3 by 2; **Specify the sensitivity and specificity of the covariate's 
misclassification**; 
  SN=1-XSN/10; 
  if SN=0.9 then FP=0.1; **False Positive equals 1-Specificity**; 
  if SN=0.7 then FP=0.3; 
 
    do ni=1 to 6; 
     nimpute=numberofimpute[ni]; 
 
prev=0; **true value of prevalence**; 
obs_prev=0; **value of observed prevalence**; 
obs_bias=0;**the bias of the observed prevalence**; 
SN_U=0; **The sensitivity of the observed response (diagnosis U)**; 
SP_U=0; **The specificity of the observed response (diagnosis U)**; 
 
t_prev=0; 
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t_bias=0; 
t_relbias=0; 
t_stbias=0; 
t_tvar=0; 
t_coverage=0; 
 
t_bcprev=0; 
t_bcbias=0; 
t_bcrelbias=0; 
t_bcstbias=0; 
t_bctvar=0; 
t_bccoverage=0; 
 
o_prev=0; 
o_bias=0; 
o_relbias=0; 
o_stbias=0; 
o_tvar=0; 
o_coverage=0; 
 
o_bcprev=0; 
o_bcbias=0; 
o_bcrelbias=0; 
o_bcstbias=0; 
o_bctvar=0; 
o_bccoverage=0; 
 
c_prev=0; 
c_bias=0; 
c_relbias=0; 
c_stbias=0; 
c_tvar=0; 
c_coverage=0; 
 
c_bcprev=0; 
c_bcbias=0; 
c_bcrelbias=0; 
c_bcstbias=0; 
c_bctvar=0; 
c_bccoverage=0; 
 
oc_prev=0; 
oc_bias=0; 
oc_relbias=0; 
oc_stbias=0; 
oc_tvar=0; 
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oc_coverage=0; 
 
oc_bcprev=0; 
oc_bcbias=0; 
oc_bcrelbias=0; 
oc_bcstbias=0; 
oc_bctvar=0; 
oc_bccoverage=0; 
 
t_yimpute=j(ntot,nimpute,.); 
t_bcyimpute=j(ntot,nimpute,.); 
o_yimpute=j(ntot,nimpute,.); **O_YIMPUTE: imputed values of MI in frequentist with 
observed disease status only**; 
o_bcyimpute=j(ntot,nimpute,.); 
c_yimpute=j(ntot,nimpute,.); **C_YIMPUTE: imputed values of MI in frequentist with imputed 
covariates**;  
c_bcyimpute=j(ntot,nimpute,.); 
oc_yimpute=j(ntot,nimpute,.); **OC_YIMPUTE: imputed values of MI in frequentist with 
observed disease status and covariates**; 
oc_bcyimpute=j(ntot,nimpute,.); 
 
**Main Body of Simulation**; 
do r=1 to nsim; 
**Generate a continuous covariate data and a binary covariate data**; 
x1=j(ntot,1,.); 
call randseed(seed1); 
call randgen (x1,'normal',0,1); 
x2=j(ntot,1,.); 
call randseed(seed2); 
call randgen (x2,'Bernoulli',.50); 
**Create true disease status**; 
do i=1 to ntot; 
 pi=exp(beta0+beta1*x1[i]+beta2*x2[i])/(1+exp(beta0+beta1*x1[i]+beta2*x2[i])); 
 call randseed(seed3); 
 call randgen(yi,'bernoulli',pi); 
 alldata[i,2]=yi; 
end; 
prev1=sum(alldata[,2])/ntot; 
ytrue=alldata[,2]; 
prev=prev+prev1; 
**Create observed disease status**; 
do i=1 to ntot; 
 underp=1/(1+exp(-(rho0+rho1*x1[i]+rho2*x2[i]))); 
 call randseed(seed4);  
 call randgen(indobs,'bernoulli',underp); **Misclassification probability conditional on 
true covariates**; 
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 if alldata[i,2]=1 then alldata[i,3]=indobs; 
 else alldata[i,3]=0; 
end; 
obsprev1=sum(alldata[,3])/ntot; 
obs_prev=obs_prev+obsprev1; 
obs_bias1=prev1-obsprev1; 
obs_bias=obs_bias+obs_bias1; 
 
**Estimate the sensitivity and specificity of the diagnosis(U)**; 
SN_count=0; 
SP_count=0; 
do i=1 to ntot; 
 if alldata[i,2]=1 then do; 
  if alldata[i,3]=1 then SN_count=SN_count+1; 
 end; 
 if alldata[i,2]=0 then do; 
  if alldata[i,3]=0 then SP_count=SP_count+1; 
 end; 
end; 
SN_U=SN_U+SN_count/sum(alldata[,2]); 
SP_U=SP_U+SP_count/(ntot-sum(alldata[,2]));  
 
**Create observed covariates**; 
**Non-differential**; 
m1=j(ntot,1,.); **The observed values of the continuous covariate**; 
epsilon=j(ntot,1,.); 
call randseed(seed5); 
call randgen(epsilon,'normal',0,MEvar); 
do i=1 to ntot; 
 m1[i]=x1[i]+epsilon[i]; 
end; 
 
m2=j(ntot,1,.); **The measurement of the dichotomous covariate which is assumed to be non-
differential**; 
call randseed(seed6); 
call randgen(indobs1,'bernoulli',SN); 
call randseed(seed7); 
call randgen(indobs2,'bernoulli',FP); 
do i=1 to ntot; 
 if x2[i]=1 then m2[i,1] = indobs1[i]; 
 else m2[i,1]= indobs2[i]; 
end; 
  
**Create indicator for membership in the validation cohort and output validation cohort data into 
a new dataset for analysis**; 
**MCAR**; 
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call randseed(seed8); 
call randgen(indval,'uniform'); 
validss=valrate*ntot; 
temp=rank(indval); 
**Create indicator for membership in the validation cohort and output validation cohort data into 
a new dataset for analysis**; 
**MAR**; 
call randseed(seed8); 
call randgen(indval,'uniform'); 
validss=valrate*ntot; 
temp=rank(indval#(alldata[,3]+0.5)); 
**Create indicator for membership in the validation cohort and output validation cohort data into 
a new dataset for analysis**; 
**MNAR**; 
call randseed(seed8); 
call randgen(indval,'uniform'); 
validss=valrate*ntot; 
temp=rank(indval#(alldata[,2]+0.5)); 
yset=j(validss,9,1); 
count=0; 
do i=1 to ntot; 
 if temp[i]<=validss then do; 
  alldata[i,1]=1; 
  count=count+1; 
  yset[count,1]=alldata[i,2]; 
  yset[count,2]=1; 
  yset[count,3]=alldata[i,3]; 
  yset[count,4]=x1[i]; 
  yset[count,5]=x2[i]; 
  yset[count,7]=m1[i]; 
  yset[count,9]=m2[i]; 
 end; 
 if temp[i]>validss then alldata[i,1]=0; 
end; 
 
**Impute the true covariates**; 
call regress(yset[,4],yset[,{6 7}],phi,covphi); 
call betagen(phimat,phi,covphi,nimpute,seed9); **Impute multiple coefficients for x1**; 
ix1=j(ntot,nimpute,.); 
do k=1 to nimpute; 
 ix1_fill=j(ntot,1,.); 
 do i=1 to ntot; 
  if alldata[i,1]=1 then ix1_fill[i]=x1[i]; 
  else ix1_fill[i]=phimat[k,1]+phimat[k,2]*m1[i]; **Linear regression to predict 
true covariates**; 
 end; 
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 ix1[,k]=ix1_fill; 
end; 
call biascor(x2delta,x2covdelta,yset[,5],yset[,
48
],b); 
call betagen(deltamat,x2delta,x2covdelta,nimpute,seed10); 
ix2=j(ntot,nimpute,.); 
do k=1 to nimpute; 
 ix2_fill=j(ntot,1,.); 
 do i=1 to ntot; 
  if alldata[i,1]=0 then do; 
  
 epx2=exp(deltamat[k,1]+deltamat[k,2]*m2[i])/(1+exp(deltamat[k,1]+deltamat[k,2]*m2[i
])); 
   call randseed(seed11); 
   call randgen(ex,'bernoulli',epx2); 
   ix2_fill[i]=ex; 
  end; 
  else if alldata[i,1]=1 then ix2_fill[i]=x2[i]; 
 end; 
 ix2[,k]=ix2_fill; 
end; 
 
**Original with true covariates ie the disease model**; 
call binest(t_beta,t_cov,yset[,1],yset[,{2 4 5}],b); 
call betagen(tbetamat,t_beta,t_cov,nimpute,seed12); 
t_storval=j(nimpute,1,.); 
t_storvar=j(nimpute,1,.); 
do k=1 to nimpute; 
 t_prob=j(ntot,1,.); 
 tfill_vec=j(ntot,1,.); 
 t_indvar=j(ntot,1,.); 
 do i=1 to ntot; 
  if tbetamat[k,1]+tbetamat[k,2]*x1[i]+tbetamat[k,3]*x2[i]>0 then tp=1/(1+exp(-
(tbetamat[k,1]+tbetamat[k,2]*x1[i]+tbetamat[k,3]*x2[i]))); 
  else 
tp=exp(tbetamat[k,1]+tbetamat[k,2]*x1[i]+tbetamat[k,3]*x2[i])/(1+exp(tbetamat[k,1]+tbetamat[
k,2]*x1[i]+tbetamat[k,3]*x2[i])); 
  t_prob[i]=tp; 
  if alldata[i,1]=0 then do; 
   call randseed(seed13,0); 
   call randgen(tfill,'bernoulli',t_prob[i]); 
   tfill_vec[i]=tfill; 
  end; 
  else if alldata[i,1]=1 then tfill_vec[i]=alldata[i,2]; 
 end; 
 t_yimpute[,k]=tfill_vec; 
 tprev=sum(t_yimpute[,k])/ntot; 
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 do i=1 to ntot; 
  t_indvar[i]=t_prob[i]*(1-t_prob[i]); 
 end; 
 tpredvar=sum(t_indvar)/ntot**2; 
 t_storval[k]=tprev; 
 t_storvar[k]=tpredvar; 
end; 
 
t_prev0=sum(t_storval)/nimpute; 
t_prev=t_prev+t_prev0; 
t_bias0=t_prev0-prev1; 
t_bias=t_bias+t_bias0; 
t_relbias0=t_bias0/prev1; **The bias relative to the true prevelance**; 
t_relbias=t_relbias+t_relbias0; 
t_wvar=sum(t_storvar)/nimpute;  **Within Imputation Variance of Bias Correction MIM based 
on observed response only**; 
 
do q=1 to nimpute; 
 t_bvar=sum((t_storval[q]-sum(t_storval)/nimpute)**2)/(nimpute-1); 
end; 
 
t_tvar0=t_wvar+(1+1/nimpute)*t_bvar; **Total variability of Bias Correction MIM based on 
observed response only**; 
t_tvar=t_tvar+t_tvar0; 
t_SE=sqrt(t_tvar0); 
t_stbias0=t_bias0/t_SE; 
t_stbias=t_stbias+t_stbias0; 
t_LCI=t_prev0-1.96*t_SE; 
t_UCI=t_prev0+1.96*t_SE; 
ta=t_LCI<=prev1 & t_UCI>=prev1; 
t_coverage=t_coverage+ta; 
 
**Bias Correction with true covariates ie the disease model**; 
call biascor(t_bcbeta,t_bccov,yset[,1],yset[,{2 4 5}],b); 
call betagen(tbcbetamat,t_bcbeta,t_bccov,nimpute,seed14); 
t_bcstorval=j(nimpute,1,.); 
t_bcstorvar=j(nimpute,1,.); 
 
do k=1 to nimpute; 
 t_bcprob=j(ntot,1,.); 
 tbcfill_vec=j(ntot,1,.); 
 t_bcindvar=j(ntot,1,.); 
 do i=1 to ntot; 
  if tbcbetamat[k,1]+tbcbetamat[k,2]*x1[i]+tbcbetamat[k,3]*x2[i]>0 then 
tbcp=1/(1+exp(-(tbcbetamat[k,1]+tbcbetamat[k,2]*x1[i]+tbcbetamat[k,3]*x2[i]))); 
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  else 
tbcp=exp(tbcbetamat[k,1]+tbcbetamat[k,2]*x1[i]+tbcbetamat[k,3]*x2[i])/(1+exp(tbcbetamat[k,1
]+tbcbetamat[k,2]*x1[i]+tbcbetamat[k,3]*x2[i])); 
  t_bcprob[i]=tbcp; 
   if alldata[i,1]=0 then do; 
    call randseed(seed15,0); 
    call randgen(tbcfill,'bernoulli',t_bcprob[i]); 
    tbcfill_vec[i]=tbcfill; 
   end; 
   else if alldata[i,1]=1 then tbcfill_vec[i]=alldata[i,2]; 
 end; 
 t_bcyimpute[,k]=tbcfill_vec; 
 tbcprev=sum(t_bcyimpute[,k])/ntot; 
 do i=1 to ntot; 
  t_bcindvar[i]=t_bcprob[i]*(1-t_bcprob[i]); 
 end; 
 tbcpredvar=sum(t_bcindvar)/ntot**2; 
 t_bcstorval[k]=tbcprev; 
 t_bcstorvar[k]=tbcpredvar; 
end; 
 
t_bcprev0=sum(t_bcstorval)/nimpute; 
t_bcprev=t_bcprev+t_bcprev0; 
t_bcbias0=t_bcprev0-prev1; 
t_bcbias=t_bcbias+t_bcbias0; 
t_bcrelbias0=t_bcbias0/prev1; **The bias relative to the true prevelance**; 
t_bcrelbias=t_bcrelbias+t_bcrelbias0; 
t_bcwvar=sum(t_bcstorvar)/nimpute;  **Within Imputation Variance of Bias Correction MIM 
based on observed response only**; 
 
do q=1 to nimpute; 
 t_bcbvar=sum((t_bcstorval[q]-sum(t_bcstorval)/nimpute)**2)/(nimpute-1); 
end; 
 
t_bctvar0=t_bcwvar+(1+1/nimpute)*t_bcbvar; **Total variability of Bias Correction MIM based 
on observed response only**; 
t_bctvar=t_bctvar+t_bctvar0; 
 
t_bcSE=sqrt(t_bctvar0); 
t_bcstbias0=t_bcbias0/t_bcSE; 
t_bcstbias=t_bcstbias+t_bcstbias0; 
t_bcLCI=t_bcprev0-1.96*t_bcSE; 
t_bcUCI=t_bcprev0+1.96*t_bcSE; 
tbca=t_bcLCI<=prev1 & t_bcUCI>=prev1; 
t_bccoverage=t_bccoverage+tbca; 
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**Original only with observed response**; 
call binest(obeta,ocov,yset[,1],yset[,2:3],b); 
call betagen(obetamat,obeta,ocov,nimpute,seed16); 
o_storval=j(nimpute,1,.); 
o_storvar=j(nimpute,1,.); 
 
do k=1 to nimpute; 
 o_prob=j(ntot,1,.); 
 ofill_vec=j(ntot,1,.); 
 o_indvar=j(ntot,1,.); 
 do i=1 to ntot; 
  if obetamat[k,1]+obetamat[k,2]*alldata[i,3]>0 then op=1/(1+exp(-
(obetamat[k,1]+obetamat[k,2]*alldata[i,3]))); 
  else 
op=exp(obetamat[k,1]+obetamat[k,2]*alldata[i,3])/(1+exp(obetamat[k,1]+obetamat[k,2]*alldata[
i,3])); 
  o_prob[i]=op; 
   if alldata[i,1]=0 then do; 
    call randseed(seed17); 
    call randgen(o_fill,'bernoulli',o_prob[i]); 
    ofill_vec[i]=o_fill; 
   end; 
   else if alldata[i,1]=1 then ofill_vec[i]=alldata[i,2]; 
 end; 
 o_yimpute[,k]=ofill_vec; 
 oprev=sum(o_yimpute[,k])/ntot; 
 do i=1 to ntot; 
  o_indvar[i]=o_prob[i]*(1-o_prob[i]); 
 end; 
 opredvar=sum(o_indvar)/ntot**2; 
 o_storval[k]=oprev; 
 o_storvar[k]=opredvar; 
end; 
 
o_prev0=sum(o_storval)/nimpute; 
o_prev=o_prev+o_prev0; 
o_bias0=o_prev0-prev1; 
o_bias=o_bias+o_bias0; 
 
o_relbias0=o_bias0/prev1; **The bias relative to the true prevelance**; 
o_relbias=o_relbias+o_relbias0; 
o_wvar=sum(o_storvar)/nimpute;  **Within Imputation Variance of Bias Correction MIM based 
on observed response only**; 
 
do q=1 to nimpute; 
 o_bvar=sum((o_storval[q]-sum(o_storval)/nimpute)**2)/(nimpute-1); 
117 
  
 
end; 
 
o_tvar0=o_wvar+(1+1/nimpute)*o_bvar; **Total variability of Bias Correction MIM based on 
observed response only**; 
o_tvar=o_tvar+o_tvar0; 
o_SE=sqrt(o_tvar0); 
o_stbias0=o_bias0/o_SE; 
o_stbias=o_stbias+o_stbias0; 
o_LCI=o_prev0-1.96*o_SE; 
o_UCI=o_prev0+1.96*o_SE; 
oa=o_LCI<=prev1 & prev1<=o_UCI; 
o_coverage=o_coverage+oa; 
 
**Bias Correction only with observed response**; 
call biascor(obcbeta,obccov,yset[,1],yset[,2:3],b); 
call betagen(obcbetamat,obcbeta,obccov,nimpute,seed18); 
o_bcstorval=j(nimpute,1,.); 
o_bcstorvar=j(nimpute,1,.); 
 
do k=1 to nimpute; 
 o_bcprob=j(ntot,1,.); 
 obcfill_vec=j(ntot,1,.); 
 o_bcindvar=j(ntot,1,.); 
 do i=1 to ntot; 
  if obcbetamat[k,1]+obcbetamat[k,2]*alldata[i,3]>0 then obcp=1/(1+exp(-
(obcbetamat[k,1]+obcbetamat[k,2]*alldata[i,3]))); 
  else 
obcp=exp(obcbetamat[k,1]+obcbetamat[k,2]*alldata[i,3])/(1+exp(obcbetamat[k,1]+obcbetamat[
k,2]*alldata[i,3])); 
  o_bcprob[i]=obcp; 
  if alldata[i,1]=0 then do; 
   call randseed(seed19); 
   call randgen(o_bcfill,'bernoulli',o_bcprob[i]); 
   obcfill_vec[i]=o_bcfill; 
  end; 
  else if alldata[i,1]=1 then obcfill_vec[i]=alldata[i,2]; 
 end; 
 o_bcyimpute[,k]=obcfill_vec; 
 obcprev=sum(o_bcyimpute[,k])/ntot; 
 do i=1 to ntot; 
  o_bcindvar[i]=o_bcprob[i]*(1-o_bcprob[i]); 
 end; 
 obcpredvar=sum(o_bcindvar)/ntot**2; 
 o_bcstorval[k]=obcprev; 
 o_bcstorvar[k]=obcpredvar; 
end; 
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o_bcprev0=sum(o_bcstorval)/nimpute; 
o_bcprev=o_bcprev+o_bcprev0; 
o_bcbias0=o_bcprev0-prev1; 
o_bcbias=o_bcbias+o_bcbias0; 
o_bcrelbias0=o_bcbias0/prev1; **The bias relative to the true prevelance**; 
o_bcrelbias=o_bcrelbias+o_bcrelbias0; 
o_bcwvar=sum(o_bcstorvar)/nimpute;  **Within Imputation Variance of Bias Correction MIM 
based on observed response only**; 
 
do q=1 to nimpute; 
 o_bcbvar=sum((o_bcstorval[q]-sum(o_bcstorval)/nimpute)**2)/(nimpute-1); 
end; 
 
o_bctvar0=o_bcwvar+(1+1/nimpute)*o_bcbvar; **Total variability of Bias Correction MIM 
based on observed response only**; 
o_bctvar=o_bctvar+o_bctvar0; 
o_bcSE=sqrt(o_bctvar0); 
o_bcstbias0=o_bcbias0/o_bcSE; 
o_bcstbias=o_bcstbias+o_bcstbias0; 
o_bcLCI=o_bcprev0-1.96*o_bcSE; 
o_bcUCI=o_bcprev0+1.96*o_bcSE; 
obca=o_bcLCI<=prev1 & prev1<=o_bcUCI; 
o_bccoverage=o_bccoverage+obca; 
 
**Original with imputed covariates**; 
call binest(cbeta,ccov,yset[,1],yset[,{2 4 5}],b); 
call betagen(cbetamat,cbeta,ccov,nimpute,seed20); 
c_storval=j(nimpute,1,.); 
c_storvar=j(nimpute,1,.); 
 
do k=1 to nimpute; 
 c_prob=j(ntot,1,.); 
 cfill_vec=j(ntot,1,.); 
 c_indvar=j(ntot,1,.); 
 do i=1 to ntot; 
  if cbetamat[k,1]+cbetamat[k,2]*ix1[i,k]+cbetamat[k,3]*ix2[i,k]>0 then 
cp=1/(1+exp(-(cbetamat[k,1]+cbetamat[k,2]*ix1[i,k]+cbetamat[k,3]*ix2[i,k]))); 
  else 
cp=exp(cbetamat[k,1]+cbetamat[k,2]*ix1[i,k]+cbetamat[k,3]*ix2[i,k])/(1+exp(cbetamat[k,1]+cb
etamat[k,2]*ix1[i,k]+cbetamat[k,3]*ix2[i,k])); 
  c_prob[i]=cp; 
  if alldata[i,1]=0 then do; 
   call randseed(seed21,0); 
   call randgen(cfill,'bernoulli',c_prob[i]); 
   cfill_vec[i]=cfill; 
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  end; 
  else if alldata[i,1]=1 then cfill_vec[i]=alldata[i,2]; 
 end; 
 c_yimpute[,k]=cfill_vec; 
 cprev=sum(c_yimpute[,k])/ntot; 
 do i=1 to ntot; 
  c_indvar[i]=c_prob[i]*(1-c_prob[i]); 
 end; 
 cpredvar=sum(c_indvar)/ntot**2; 
 c_storval[k]=cprev; 
 c_storvar[k]=cpredvar; 
end; 
 
c_prev0=sum(c_storval)/nimpute; 
c_prev=c_prev+c_prev0; 
c_bias0=c_prev0-prev1; 
c_bias=c_bias+c_bias0; 
c_relbias0=c_bias0/prev1; 
c_relbias=c_relbias+c_relbias0; 
c_wvar=sum(c_storvar)/nimpute; **Within Imputation Variance of Bias Correction based on 
observed response and covariates**; 
 
do q=1 to nimpute; 
 c_bvar=sum((c_storval[q]-sum(c_storval)/nimpute)**2)/(nimpute-1); 
end; 
 
c_tvar0=c_wvar+(1+1/nimpute)*c_bvar; **Total Variability of Bias Correction based on 
observed response and covariates**; 
c_tvar=c_tvar+c_tvar0; 
c_SE=sqrt(c_tvar0); 
c_stbias0=c_bias0/c_SE; 
c_stbias=c_stbias+c_stbias0; 
c_LCI=c_prev0-1.96*c_SE; 
c_UCI=c_prev0+1.96*c_SE; 
ca=c_LCI<=prev1 & prev1<=c_UCI; 
c_coverage=c_coverage+ca; 
 
**Bias Correction with imputed covariates**; 
call biascor(cbc_beta,cbc_cov,yset[,1],yset[,{2 4 5}],b); 
call betagen(cbcbetamat,cbc_beta,cbc_cov,nimpute,seed22); 
c_bcstorval=j(nimpute,1,.); 
c_bcstorvar=j(nimpute,1,.); 
 
do k=1 to nimpute; 
 c_bcprob=j(ntot,1,.); 
 cbcfill_vec=j(ntot,1,.); 
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 c_bcindvar=j(ntot,1,.); 
 do i=1 to ntot; 
  if cbcbetamat[k,1]+cbcbetamat[k,2]*ix1[i,k]+cbcbetamat[k,3]*ix2[i,k]>0 then 
cbcp=1/(1+exp(-(cbcbetamat[k,1]+cbcbetamat[k,2]*ix1[i,k]+cbcbetamat[k,3]*ix2[i,k]))); 
  else 
cbcp=exp(cbcbetamat[k,1]+cbcbetamat[k,2]*ix1[i,k]+cbcbetamat[k,3]*ix2[i,k])/(1+exp(cbcbeta
mat[k,1]+cbcbetamat[k,2]*ix1[i,k]+cbcbetamat[k,3]*ix2[i,k])); 
  c_bcprob[i]=cbcp; 
  if alldata[i,1]=0 then do; 
   call randseed(seed23,0); 
   call randgen(cbcfill,'bernoulli',c_bcprob[i]); 
   cbcfill_vec[i]=cbcfill; 
  end; 
  else if alldata[i,1]=1 then cfill_vec[i]=alldata[i,2]; 
 end; 
 c_bcyimpute[,k]=cbcfill_vec; 
 cbcprev=sum(c_bcyimpute[,k])/ntot; 
 do i=1 to ntot; 
  c_bcindvar[i]=c_bcprob[i]*(1-c_bcprob[i]); 
 end; 
 cbcpredvar=sum(c_bcindvar)/ntot**2; 
 c_bcstorval[k]=cbcprev; 
 c_bcstorvar[k]=cbcpredvar; 
end; 
 
c_bcprev0=sum(c_bcstorval)/nimpute; 
c_bcprev=c_bcprev+c_bcprev0; 
c_bcbias0=c_bcprev0-prev1; 
c_bcbias=c_bcbias+c_bcbias0; 
c_bcrelbias0=c_bcbias0/prev1; 
c_bcrelbias=c_bcrelbias+c_bcrelbias0; 
c_bcwvar=sum(c_bcstorvar)/nimpute; **Within Imputation Variance of Bias Correction based 
on observed response and covariates**; 
 
do q=1 to nimpute; 
 c_bcbvar=sum((c_bcstorval[q]-sum(c_bcstorval)/nimpute)**2)/(nimpute-1); 
end; 
 
c_bctvar0=c_bcwvar+(1+1/nimpute)*c_bcbvar; **Total Variability of Bias Correction based on 
observed response and covariates**; 
c_bctvar=c_bctvar+c_bctvar0; 
c_bcSE=sqrt(c_bctvar0); 
c_bcstbias0=c_bcbias0/c_bcSE; 
c_bcstbias=c_bcstbias+c_bcstbias0; 
c_bcLCI=c_bcprev0-1.96*c_bcSE; 
c_bcUCI=c_bcprev0+1.96*c_bcSE; 
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cbca=c_bcLCI<=prev1 & prev1<=c_bcUCI; 
c_bccoverage=c_bccoverage+cbca; 
 
**Original with observed response and imputed covariates**; 
call binest(ocbeta,occov,yset[,1],yset[,2:5],b); 
call betagen(ocbetamat,ocbeta,occov,nimpute,seed24); 
oc_storval=j(nimpute,1,.); 
oc_storvar=j(nimpute,1,.); 
 
do k=1 to nimpute; 
 oc_prob=j(ntot,1,.); 
 ocfill_vec=j(ntot,1,.); 
 oc_indvar=j(ntot,1,.); 
 do i=1 to ntot; 
  if 
ocbetamat[k,1]+ocbetamat[k,2]*alldata[i,3]+ocbetamat[k,3]*ix1[i,k]+ocbetamat[k,4]*ix2[i,k]>0 
then ocpv=1/(1+exp(-
(ocbetamat[k,1]+ocbetamat[k,2]*alldata[i,3]+ocbetamat[k,3]*ix1[i,k]+ocbetamat[k,4]*ix2[i,k]))); 
  else  
ocpv=exp(ocbetamat[k,1]+ocbetamat[k,2]*alldata[i,3]+ocbetamat[k,3]*ix1[i,k]+ocbetamat[k,4]*
ix2[i,k])/(1+exp(ocbetamat[k,1]+ocbetamat[k,2]*alldata[i,3]+ocbetamat[k,3]*ix1[i,k]+ocbetamat
[k,4]*ix2[i,k])); 
  oc_prob[i]=ocpv; 
  if alldata[i,1]=0 then do; 
   call randseed(seed25,0); 
   call randgen(ocfill,'bernoulli',oc_prob[i]); 
   ocfill_vec[i]=ocfill; 
  end; 
  else if alldata[i,1]=1 then ocfill_vec[i]=alldata[i,2]; 
 end; 
 oc_yimpute[,k]=ocfill_vec; 
 ocpredprev=sum(oc_yimpute[,k])/ntot; 
 do i=1 to ntot; 
  oc_indvar[i]=oc_prob[i]*(1-oc_prob[i]); 
 end; 
 ocpredvar=sum(oc_indvar)/ntot**2; 
 oc_storval[k]=ocpredprev; 
 oc_storvar[k]=ocpredvar; 
end; 
 
oc_prev0=(sum(oc_storval)/nimpute); 
oc_prev=oc_prev+oc_prev0; 
oc_bias0=oc_prev0-prev1; 
oc_bias=oc_bias+oc_bias0; 
oc_relbias0=oc_bias0/prev1; 
oc_relbias=oc_relbias+oc_relbias0; 
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oc_wvar=sum(oc_storvar)/nimpute; **Within Imputation of logistic MIM based on observed 
response and covariates**; 
 
do q=1 to nimpute; 
 oc_bvar=sum((oc_storval[q]-sum(oc_storval)/nimpute)**2)/(nimpute-1); 
end; 
 
oc_tvar0=oc_wvar+(1+1/nimpute)*oc_bvar; **Total variability of logistic MIM based on 
observed response and imputed covariates**; 
oc_tvar=oc_tvar+oc_tvar0; 
oc_SE=sqrt(oc_tvar0); 
oc_stbias0=oc_bias0/oc_SE; 
oc_stbias=oc_stbias+oc_stbias0; 
oc_LCI=oc_prev0-1.96*oc_SE; 
oc_UCI=oc_prev0+1.96*oc_SE; 
oca=oc_LCI<=prev1 & prev1<=oc_UCI;  
oc_coverage=oc_coverage+oca; 
 
**Bias Correction with observed response and imputed covariates**; 
call biascor(ocbcbeta,ocbccov,yset[,1],yset[,2:5],b); 
call betagen(ocbcbetamat,ocbcbeta,ocbccov,nimpute,seed26); 
oc_bcstorval=j(nimpute,1,.); 
oc_bcstorvar=j(nimpute,1,.); 
 
do k=1 to nimpute; 
 oc_bcprob=j(ntot,1,.); 
 ocbcfill_vec=j(ntot,1,.); 
 oc_bcindvar=j(ntot,1,.); 
 do i=1 to ntot; 
  if 
ocbcbetamat[k,1]+ocbcbetamat[k,2]*alldata[i,3]+ocbcbetamat[k,3]*ix1[i,k]+ocbcbetamat[k,4]*i
x2[i,k]>0 then ocbcpv=1/(1+exp(-
(ocbcbetamat[k,1]+ocbcbetamat[k,2]*alldata[i,3]+ocbcbetamat[k,3]*ix1[i,k]+ocbcbetamat[k,4]*
ix2[i,k]))); 
  else  
ocbcpv=exp(ocbcbetamat[k,1]+ocbcbetamat[k,2]*alldata[i,3]+ocbcbetamat[k,3]*ix1[i,k]+ocbcbe
tamat[k,4]*ix2[i,k])/(1+exp(ocbcbetamat[k,1]+ocbcbetamat[k,2]*alldata[i,3]+ocbcbetamat[k,3]*
ix1[i,k]+ocbcbetamat[k,4]*ix2[i,k])); 
  oc_bcprob[i]=ocbcpv; 
  if alldata[i,1]=0 then do; 
   call randseed(seed27,0); 
   call randgen(ocbcfill,'bernoulli',oc_bcprob[i]); 
   ocbcfill_vec[i]=ocbcfill; 
  end; 
  else if alldata[i,1]=1 then ocbcfill_vec[i]=alldata[i,2]; 
 end; 
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 oc_bcyimpute[,k]=ocbcfill_vec; 
 ocbcpredprev=sum(oc_bcyimpute[,k])/ntot; 
 do i=1 to ntot; 
  oc_bcindvar[i]=oc_bcprob[i]*(1-oc_bcprob[i]); 
 end; 
 ocbcpredvar=sum(oc_bcindvar)/ntot**2; 
 oc_bcstorval[k]=ocbcpredprev; 
 oc_bcstorvar[k]=ocbcpredvar; 
end; 
 
oc_bcprev0=(sum(oc_bcstorval)/nimpute); 
oc_bcprev=oc_bcprev+oc_bcprev0; 
oc_bcbias0=oc_bcprev0-prev1; 
oc_bcbias=oc_bcbias+oc_bcbias0; 
oc_bcrelbias0=oc_bcbias0/prev1; 
oc_bcrelbias=oc_bcrelbias+oc_bcrelbias0; 
oc_bcwvar=sum(oc_bcstorvar)/nimpute; **Within Imputation of logistic MIM based on 
observed response and covariates**; 
 
do q=1 to nimpute; 
 oc_bcbvar=sum((oc_bcstorval[q]-sum(oc_bcstorval)/nimpute)**2)/(nimpute-1); 
end; 
 
oc_bctvar0=oc_bcwvar+(1+1/nimpute)*oc_bcbvar; **Total variability of logistic MIM based on 
observed response and imputed covariates**; 
oc_bctvar=oc_bctvar+oc_bctvar0; 
oc_bcSE=sqrt(oc_bctvar0); 
oc_bcstbias0=oc_bcbias0/oc_bcSE; 
oc_bcstbias=oc_bcstbias+oc_bcstbias0; 
oc_bcLCI=oc_bcprev0-1.96*oc_bcSE; 
oc_bcUCI=oc_bcprev0+1.96*oc_bcSE; 
ocbca=oc_bcLCI<=prev1 & prev1<=oc_bcUCI; 
oc_bccoverage=oc_bccoverage+ocbca; 
end; **END of the simulation**; 
 
prev=prev/nsim; 
obs_prev=obs_prev/nsim; 
obs_bias=obs_bias/nsim; 
SN_U=SN_U/nsim; 
SP_U=SP_U/nsim; 
 
t_prev=t_prev/nsim; 
t_bias=t_bias/nsim; 
t_relbias=t_relbias/nsim; 
t_stbias=t_stbias/nsim; 
t_tvar=t_tvar/nsim; 
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t_mse=t_tvar+t_bias**2; 
t_rmse=sqrt(t_mse); 
t_coverage=t_coverage/nsim; 
 
t_bcprev=t_bcprev/nsim; 
t_bcbias=t_bcbias/nsim; 
t_bcrelbias=t_bcrelbias/nsim; 
t_bcstbias=t_bcstbias/nsim; 
t_bctvar=t_bctvar/nsim; 
t_bcmse=t_bctvar+t_bcbias**2; 
t_bcrmse=sqrt(t_bcmse); 
t_bccoverage=t_bccoverage/nsim; 
 
o_prev=o_prev/nsim; 
o_bias=o_bias/nsim; 
o_relbias=o_relbias/nsim; 
o_stbias=o_stbias/nsim; 
o_tvar=o_tvar/nsim; 
o_mse=o_tvar+o_bias**2; 
o_rmse=sqrt(o_mse); 
o_coverage=o_coverage/nsim; 
 
o_bcprev=o_bcprev/nsim; 
o_bcbias=o_bcbias/nsim; 
o_bcrelbias=o_bcrelbias/nsim; 
o_bcstbias=o_bcstbias/nsim; 
o_bctvar=o_bctvar/nsim; 
o_bcmse=o_bctvar+o_bcbias**2; 
o_bcrmse=sqrt(o_bcmse); 
o_bccoverage=o_bccoverage/nsim; 
 
c_prev=c_prev/nsim; 
c_bias=c_bias/nsim; 
c_relbias=c_relbias/nsim; 
c_stbias=c_stbias/nsim; 
c_tvar=c_tvar/nsim; 
c_mse=c_tvar+c_bias**2; 
c_rmse=sqrt(c_mse); 
c_coverage=c_coverage/nsim; 
 
c_bcprev=c_bcprev/nsim; 
c_bcbias=c_bcbias/nsim; 
c_bcrelbias=c_bcrelbias/nsim; 
c_bcstbias=c_bcstbias/nsim; 
c_bctvar=c_bctvar/nsim; 
c_bcmse=c_bctvar+c_bcbias**2; 
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c_bcrmse=sqrt(c_bcmse); 
c_bccoverage=c_bccoverage/nsim; 
 
oc_prev=oc_prev/nsim; 
oc_bias=oc_bias/nsim; 
oc_relbias=oc_relbias/nsim; 
oc_stbias=oc_stbias/nsim; 
oc_tvar=oc_tvar/nsim; 
oc_mse=oc_tvar+oc_bias**2; 
oc_rmse=sqrt(oc_mse); 
oc_coverage=oc_coverage/nsim; 
 
oc_bcprev=oc_bcprev/nsim; 
oc_bcbias=oc_bcbias/nsim; 
oc_bcrelbias=oc_bcrelbias/nsim; 
oc_bcstbias=oc_bcstbias/nsim; 
oc_bctvar=oc_bctvar/nsim; 
oc_bcmse=oc_bctvar+oc_bcbias**2; 
oc_bcrmse=sqrt(oc_bcmse); 
oc_bccoverage=oc_bccoverage/nsim; 
 
Parameter=ntot||sensitivity||valrate||nimpute||MEvar||SN||FP; 
OBS=nsim||prev||obs_prev||obs_bias||SN_U||SP_U; 
TMIM=t_prev||t_bias||t_relbias||t_stbias||t_tvar||t_rmse||t_coverage; 
TBCMIM=t_bcprev||t_bcbias||t_bcrelbias||t_bcstbias||t_bctvar||t_bcrmse||t_bccoverage; 
OMIM=o_prev||o_bias||o_relbias||o_stbias||o_tvar||o_rmse||o_coverage; 
OBCMIM=o_bcprev||o_bcbias||o_bcrelbias||o_bcstbias||o_bctvar||o_bcrmse||o_bccoverage; 
CMIM=c_prev||c_bias||c_relbias||c_stbias||c_tvar||c_rmse||c_coverage; 
CBCMIM=c_bcprev||c_bcbias||c_bcrelbias||c_bcstbias||c_bctvar||c_bcrmse||c_bccoverage;  
OCMIM=oc_prev||oc_bias||oc_relbias||oc_stbias||oc_tvar||oc_rmse||oc_coverage; 
OCBCMIM=oc_bcprev||oc_bcbias||oc_bcrelbias||oc_bcstbias||oc_bctvar||oc_bcrmse||oc_bccover
age; 
Result1=Parameter||OBS||TMIM||TBCMIM||OMIM||OBCMIM||CMIM||CBCMIM||OCMIM||OC
BCMIM; 
 
ResultAll[1#(MEvar=1)+13#(MEvar=2)+0#(SN=0.9)+6#(SN=0.7)+0#(nimpute=3)+1#(nimpute
=5)+2#(nimpute=10)+3#(nimpute=15)+4#(nimpute=20)+5#(nimpute=40),]=Result1; 
 
Varnames={TotalNumbers Sensitivity ValRate NImpute AddVar XSensitivity XFalsePositive 
SimulationNumber Prevalence ObservedPrevalence ObservedPrevBias TestUSensitiviy 
TestUSpecificity PrevT BiasT RelBiasT StBiasT TotVarT RMSET CoverageT PrevTBC 
BiasTBC RelBiasTBC StBiasTBC TotVarTBC RMSETBC CoverageTBC PrevO BiasO 
RelBiasO StBiasO TotVarO RMSEO CoverageO PrevOBC BiasOBC RelBiasOBC StBiasOBC 
TotVarOBC RMSEOBC CoverageOBC PrevC BiasC RelBiasC StBiasC TotVarC RMSEC 
CoverageC PrevCBC BiasCBC RelBiasCBC StBiasCBC TotVarCBC RMSECBC 
CoverageCBC PrevOC BiasOC RelBiasOC StBiasOC TotVarOC RMSEOC CoverageOC 
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PrevOCBC BiasOCBC RelBiasOCBC StBiasOCBC TotVarOCBC RMSEOCBC 
CoverageOCBC}; 
 
end; **END of number of imputation loop**;  
end; **END of misclassification characteristics**; 
end; **END of measurement error characteristics**; 
 
create MCAR2.MCAR2P05S65 from ResultAll [colname=varnames]; 
append from ResultAll; 
close MCAR2.MCAR2P05S65; 
 
SEED=seed1||seed2||seed3||seed4||seed5||seed6||seed7||seed8||seed9||seed10||seed11||seed12||seed1
3||seed14||seed15||seed16||seed17||seed18||seed19||seed20||seed21||seed22||seed23||seed24||seed25|
|seed26||seed27; 
 
create MCAR2.SEED2P05S65 from SEED; 
append from SEED; 
close MCAR2.SEED2P05S65; 
 
quit; 
 
 
    
    
  
    
 
    
    
    
 
    
    
   
    
    
